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ABSTRACT 
Influenza A virus (IAV) is capable of infecting a wide variety of avian and mammalian 
species, including swine.  The control of IAV in swine populations is complicated by the fact 
that the virus is endemic in contemporary herds and may circulate in any age group.  The 
detection of IAV has historically been based on testing individual pig nasal swab (virus 
detection) or serum (antibody detection) specimens.  While individual pig sampling is 
adequate for the diagnosis of clinical IAV infections, the collection of adequate numbers of 
individual pig samples is too costly and labor-intensive for routine influenza surveillance or 
large-scale ecological studies.  Therefore, the general question addressed in this dissertation 
is whether oral fluid specimens could be used to surveil IAV infections as an alternative to 
individual animal sampling.  More specifically, the aim of this research was to evaluate an 
IAV oral fluid antibody enzyme-linked immunosorbent assay (ELISA) for the detection of 
IAV nucleoprotein (NP) antibody and its use in surveillance of swine populations.  This 
question was addressed in the logical series of experiments described below.   
 
The initial objective was to determine whether diagnostic levels of IAV NP antibodies could 
be detected in swine oral fluid specimens by adapting the serum ELISA protocol to the oral 
fluid matrix (Chapter 3).  The NP antibody ELISA was selected because the NP is highly 
conserved among IAV subtypes.  The procedure for performing the NP blocking ELISA on 
oral fluid was modified from the serum testing protocol by changing sample dilution, sample 
volume, incubation time, and incubation temperature.  The detection of NP antibody was 
evaluated using pen-based oral fluid samples (n = 182) from pigs inoculated with either 
influenza A virus subtype H1N1 or H3N2 under experimental conditions and followed for 42 
days post inoculation (DPI).  NP antibodies in oral fluid were detected from DPI 7 to 42 in 
all inoculated groups, i.e., the mean sample-to-negative (S/N) ratio of influenza-inoculated 
pigs was significantly different (p < 0.0001) from uninoculated controls (unvaccinated or 
vaccinated-uninoculated groups) through this period.  Oral fluid vs. serum S/N ratios from 
the same pen showed a correlation of 0.796 (Pearson correlation coefficient, p < 0.0001).  
The results showed that oral fluid samples from influenza virus-infected pigs contained 
detectable levels of NP antibodies for ≥ 42 DPI. 
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The availability of serum and oral fluid NP ELISAs provided the tools necessary to describe 
the kinetics of IAV NP antibody (IgM, IgA, and IgG) in serum and oral fluid specimen from 
animals of defined IAV infection status (Chapter 4).  A significant oral fluid IgM response 
was only detected in unvaccinated groups.  The maximum oral fluid IgM response in these 
groups was detected at DPI 8, after which it rapidly declined.  Oral fluid IgA was detected in 
both vaccinated and unvaccinated groups on DPI 6.  Levels of oral fluid IgA remained 
relatively stable through DPI 42.  Oral fluid IgG responses in both vaccinated and 
unvaccinated groups were detected by DPI 8 and remained stable through DPI 42.  IgM 
responses in serum and oral fluid were highly correlated in unvaccinated groups (r = 0.810), 
as were serum and oral fluid IgG responses in both unvaccinated (r = 0.839) and vaccinated 
(r = 0.856) groups.  In contrast, the correlation between serum and oral fluid IgA was weak (r 
~ 0.3), regardless of vaccination status.  The results from this study demonstrated that NP-
specific IgM, IgA, and IgG antibody were detectable in serum and oral fluid and their 
ontogeny was influenced by vaccination status, the time course of the infection, and 
specimen type. 
 
The feasibility of IAV surveillance in the field was evaluated using pre-weaning oral fluid 
samples from litters of piglets in four ~12,500 sow, IAV-vaccinated, breeding herds (Chapter 
5).  All four herds were considered endemically infected with IAV based on historic 
diagnostic data.  Oral fluid samples were collected from 600 litters prior to weaning and 
serum samples from their dams after weaning.  Litter oral fluid samples were tested for IAV 
by virus isolation, quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR), 
RT-PCR subtyping, and sequencing.  Commercial NP ELISA kits and NP isotype-specific 
assays (IgM, IgA, and IgG) were used to characterize NP antibody in litter oral fluid and sow 
serum.  All litter oral fluid specimens (n = 600) were negative by virus isolation.  Twenty-
five oral fluid samples were positive by qRT-PCR, based on screening (Laboratory 1) and 
confirmatory testing (Laboratory 2).  No hemagglutinin (HA) and neuraminidase (NA) gene 
sequences were obtained, but matrix (M) gene sequences were obtained for all qRT-PCR-
positive samples submitted for sequencing (n = 18).  Genetic analysis revealed that all M 
genes sequences were identical (GenBank accession no. KF487544) and belonged to the 
triple reassortant influenza A virus M gene (TRIG M) previously identified in swine.  The 
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proportion of IgM- and IgA-positive samples was significantly higher in sow serum and litter 
oral fluid samples, respectively (p < 0.01).  Consistent with the extensive use of IAV vaccine, 
no difference was detected in the proportion of IgG- and blocking ELISA-positive sow serum 
and litter oral fluids.  This study supported the use of oral fluid sampling as a means to 
conduct IAV surveillance in pig populations and demonstrated the inapparent circulation of 
IAV in piglets. 
 
1 
 
 
 
CHAPTER 1.  DISSERTATION ORGANIZATION 
This dissertation consists of 6 chapters.  The first chapter describes is organization of the 
dissertation.  Chapter 2 is a review of “The production and distribution of antibody in the pig 
oro-respiratory system” to be submitted for publication in Veterinary Immunology and 
Immunopathology.  Chapter 3, “Detection of influenza A virus nucleoprotein antibodies in 
oral fluid specimens form pigs infected under experimental conditions using blocking 
ELISA” was published in Transboundary and Emerging Diseases.  Chapter 4, “Kinetics of 
influenza A virus nucleoprotein antibody (IgM, IgA, and IgG) in serum and oral fluid 
specimens form pigs infected under experimental conditions" has been published in Vaccine.  
Chapter 5, "Influenza A virus (IAV) surveillance using pre-weaning piglet oral fluid 
samples" has been submitted for publication in Preventive Veterinary Medicine.  The 
references, tables, and figures associated with each chapter follow the discussion section.  
The final chapter contains the General Conclusions of the dissertation. 
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CHAPTER 2.  REVIEW OF THE PRODUCTION AND DISTRIBUTION OF 
ANTIBODY IN THE PIG ORO-RESPIRATORY SYSTEM 
 
Yaowalak Panyasing, James A. Roth, Jeffrey J. Zimmerman 
 
To be submitted to Veterinary Immunology and Immunopathology 
 
ABSTRACT 
Under constant exposure to microorganisms, the oro-respiratory immune system contains and 
controls microbes using a combination of non-specific (innate) and specific (acquired) 
immune mechanisms.  Herein we focus on the processes by which antibody is produced and 
distributed to mucosal tissues and secretions in the pig oro-respiratory system.  The humoral 
immune response of the porcine oro-respiratory system is similar to other mammalian species 
in terms of the process of producing and distributing antibody to mucosal surfaces.  That is, 
antibodies are produced by plasma cells located in salivary glands and underlying mucosal 
epithelium or arrive by passive diffusion from the capillaries in the oro-respiratory tract.  
However, the porcine immune system also has unique features, e.g., an inverted lymph node 
structure and the predominance of γδ T lymphocytes in blood and mucosal tissues.  A basic 
comprehension of this process is fundamental to achieving an understanding disease 
pathogenesis, vaccine development, and disease diagnostics.  However, it should be 
recognized that our understanding of some aspects of this process are limited, e.g., 
mechanisms related to the production of antibody by lymphoid tissues in salivary glands and 
questions on the specific receptors or mechanisms that assist antibody transport into pig 
lungs.   
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INTRODUCTION 
Terrestrial animals are routinely and continuously exposed to a wide-ranging variety of 
nonpathogenic and pathogenic microorganisms via oral and airborne exposures.  For an 
animal to survive, much less thrive, under this constant barrage of microorganisms, the oro-
respiratory immune system must be able to control their replication and spread within the 
body.  This is done using a combination of non-specific (innate) and specific (acquired) 
mechanisms.  The innate immunity of the oral cavity and respiratory tract is based on 
physical barriers (mucosa, cilia, and mucins), chemical barriers (antimicrobial enzymes e.g., 
lysozymes; antimicrobial peptides, e.g., defensins and cathelicidins), phagocytic cells 
(neutrophils, macrophages) and the complement system (Murphy, 2012).  In contrast, 
acquired immunity is a two-pronged system capable of producing cell-mediated and humoral 
immune responses.  Cell-mediated immunity generally involves cytotoxic T cells and 
eliminates intracellular microorganisms via apoptosis.  Humoral immunity is mediated by 
antibody focused on the destruction of extracellular pathogens and antigens by neutralization, 
opsonization, and complement activation (Murphy, 2012).  Unlike innate immunity, acquired 
immunity gains momentum with exposure and time, and develops a memory capable of 
generating a faster and more effective response to subsequent antigenic exposure.   
 
Antibodies on mucosal surfaces and in mucosal secretions of the oro-respiratory tract are an 
important line of acquired defense.  Thus, anti-viral antibody on mucosal surfaces is the pig's 
primary immune defense against foot-and-mouth disease virus, pseudorabies virus, and 
influenza A virus (Francis and Black, 1983; Kimman et al., 1992; Larsen et al., 2000).  In 
mammals, five classes (isotypes) of immunoglobulin (IgM, IgA, IgG, IgE, and IgD) are 
recognized.  These differ in the heavy chain portion of the molecule (µ, α, γ, ε, and δ, 
respectively).  Pigs produce IgM, IgA, IgE and six subclasses of IgG (IgG1 through 6), but 
do not produce IgD (Butler et al., 2009).  Knowledge of how the humoral oro-respiratory 
immune systems functions to protect pigs is basic to an understanding of herd immunity, 
vaccine efficacy, and diagnostic medicine.   
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ANATOMY AND HISTOLOGY 
In this section we provide a brief overview of the porcine anatomy (Figure 1) and histology 
relevant to the production and distribution of antibody in the pig oro-respiratory system 
(Figure 2).   
 
Oral cavity           
The areas of the oral cavity exposed to frictional and shearing forces (gingiva, dorsal surface 
of the tongue, and hard palate) are lined by parakeratinized to completely keratinized 
stratified squamous epithelium, with an underlying layer of dense irregular collagenous 
connective tissue (Gartner and Hiatt, 2007).  The remainder of the oral cavity is covered by 
nonkeratinized stratified squamous epithelium overlying a looser type of dense, irregular, 
collagenous connective tissue. 
 
Pigs have three major salivary glands:  parotid, mandibular, and sublingual.  Minor salivary 
glands exist as scattered lobules in the mucosa and submucosa of the buccal, labial, palatal, 
and lingual regions (Nickel et al., 1979; Stembírek et al., 2012).  An adult pig produces 
approximately 15 liters of saliva daily (König and Liebich, 2004; Stembírek et al., 2012).  
Histologically, salivary glands consist of secretory and duct portions.  A secretory unit or 
"acinus" (plural: acini) is composed of secretory cells (serous and mucous cells) surrounded 
by myoepithelial cells.  The secretory cells making up the acini produce serous, mucous, or 
mixed secretions.  The parotid salivary gland produces serous secretions, the mandibular and 
sublingual glands produce mixed secretions (serous and mucous), and the minor salivary 
glands produce mucous secretions.  Acinar secretions are modified as they move through the 
intercalated, striated, and excretory ducts to the oral cavity.  In addition, striated duct cells 
synthesize the secretory component or "polymeric immunoglobulin receptor" that binds the 
J-chain of dimeric IgA and IgM (Tandler et al., 2001).  Swine and human salivary glands 
share common anatomical characteristics and physiological functions (Zhou et al., 2010), but 
not all aspects have been researched in pigs.  For example, it is not known whether the duct-
associated lymphoid tissue (DALT) in the minor salivary glands of humans is also present in 
pigs (Liebler-Tenorio and Pabst, 2006).  Salivary glands differ in the composition of their 
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secretions and in the quantity of antibody produced.  For example, the density (number per 
mm3) of IgG, IgA, IgM, and IgD secreting-cells was significantly higher in human parotid 
than submandibular salivary glands, but IgA-secreting cells were predominant in both 
(Korsrud and Brandtzaeg, 1982).   
 
Respiratory system           
Pig lungs are divided into seven lobes.  Each lung (left and right) is divided into cranial 
(apical), middle (cardiac), and caudal (diaphragmatic) lobes, but the right lung has an 
intermediate (accessory) lobe in addition to the other three (Frandson and Spurgeon, 1992).  
Distinct from humans, the pig has a “tracheal bronchus” that connects the right cranial lobe 
of the lung directly to the trachea (Maina and van Gils, 2001).   
 
The respiratory system can be broadly divided into three parts:  conducting airways (nasal 
cavity, paranasal sinus, pharynx, larynx, trachea, and bronchi), transitional airways 
(bronchioles), and the structures associated with gas exchange (alveoli).  Within the 
conducting airways, the vestibular region of the nasal cavity is lined by stratified squamous 
epithelium, whereas the remainder of the nasal cavity, the pharynx, larynx, trachea, and 
bronchi, are covered by pseudostratified ciliated columnar epithelium containing variable 
numbers of goblet cells and serous cells (Gagné and Martineau-Doizé, 1993; VanAlstine, 
2012).  The nasal and tracheal subepithelial connective tissue (lamia propria) is highly 
vascularized and contains seromucous glands and lymphoid elements, including occasional 
lymphoid nodules, mast cells, and plasma cells (Gartner and Hiatt, 2007).  Within the 
transitional airways, the ciliated cells that predominate in the anterior bronchioles are 
gradually replaced by non-ciliated bronchiolar epithelium in the posterior bronchioles 
(Tizard, 2009).  Normal bronchioles lack goblet cells, but possess non-ciliated, dome-shaped 
epithelial columnar cells with short, blunt microvilli known as "Clara cells" (Tizard, 2009).  
At the level of gas exchange, the alveoli are lined with a single layer of pneumocytes (type I 
and the larger type II).   
 
Lymph nodes         Three major lymph centers are located in the head and neck:  parotid, 
mandibular, and retropharyngeal.  The dorsal half of the head is drained by the parotid lymph 
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center, the oral cavity and salivary glands by the mandibular lymph center, and the pharynx, 
larynx, and cranial part of the trachea by the retropharyngeal lymph center (König and 
Liebich, 2004).  In the lung, lymph is drained to the bronchial and tracheobronchial lymph 
nodes located at the tracheal bifurcation (König and Liebich, 2004; Riquet et al., 1999).   
 
Anatomically, lymph nodes are divided into cortex, paracortex, and medulla.  Histologically, 
lymph nodes consist of a reticular network filled with lymphocytes, macrophages, and 
dendritic cells (Tizard, 2009).  The structure of the porcine lymph node is inverted compared 
to most mammals, with the medulla at the periphery and the cortex in the center (Binns and 
Pabst, 1994; Tizard, 2009).  Lymph enters the cortex via afferent lymphatic vessels, passes 
from the center of the node to the periphery, and exits via efferent lymphatic vessels.  
Lymphocytes in the blood stream enter the lymph node via specialized blood vessels termed 
"high endothelial venules" and return to the bloodstream through the high endothelial venules 
of the paracortex area rather than the efferent lymphatic vessels (Binns and Pabst, 1994).  For 
this reason, very few lymphocytes are found in pig lymph.   
 
Primary lymphoid follicles, composed primarily of resting B cells, are located in the cortex.   
The primary lymphoid follicle becomes a secondary lymphoid follicle when the B cells 
proliferate and differentiate in response to antigenic stimulation.  Histologically, a secondary 
lymphoid follicle consists of a mantle zone containing resting B cells (Chianini et al., 2001) 
and a germinal center composed of  (1) a light zone where immunoglobulin class switching 
and memory B cell formation occur and (2) a dark zone where B cells proliferate and 
undergo the process of somatic hypermutation (MacLennan, 1994).  It follows that the lymph 
nodes of germ-free piglets lack germinal centers until they experience an antigenic challenge 
(Anderson et al., 1974).   
 
Tonsils          Tonsils are mucosa-associated lymphoid tissue involved in initiating an 
immune response to pathogens entering the oral cavity and respiratory system.  Pigs have 
five tonsils:  the pharyngeal tonsil on the roof of the nasopharynx, tubal tonsils at the 
pharyngeal openings of the auditory tubes, paraepiglottic tonsils located craniolaterally to the 
base of the epiglottis, tonsils of the soft palate, and lingual tonsils at the root of the tongue 
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(Casteleyn et al., 2011; Nickel et al., 1979; Stembírek et al., 2012).  Tonsils do not have 
afferent lymph ducts, but lymph is drained by the lymphatic network to the mandibular 
lymph center (Belz, 1998; Binns and Pabst, 1994; Trautmann and Fiebiger, 1957).   
 
Tonsils are characterized as follicular or non-follicular by the presence or absence of blind 
pouches (tonsillar crypts) that function in immune surveillance.  Tonsillar crypts extend from 
the surface to the underlying lymphoid tissue (Belz, 1998; Trautmann and Fiebiger, 1957).  
The tonsils of the soft palate, tubal tonsils and paraepiglottic tonsils are follicular, whereas 
the pharyngeal and lingual tonsils are non-follicular (Trautmann and Fiebiger, 1957).  All 
tonsils are covered by non-keratinized stratified squamous epithelium, but in follicular tonsils 
this layer extends through the first portion of the crypt after which it transitions to thinner 
stratified squamous epithelium highly infiltrated by lymphocytes (lymphoepithelium).  
Within the crypts, occasional membranous cells (M cells) and goblet cells are found between 
epithelial cells and lymphocytes, macrophages, and plasma cells migrate within and through 
the lymphoepithelium (Horter et al., 2003).  Lymphoid follicles containing B cells 
surrounded by T cells are located beneath the lymphoepithelium, (Bianchi et al., 1992; Salles 
et al., 2000).   
 
Bronchus-associated lymphoid tissue (BALT)          BALT most commonly consists of a 
single lymphoid follicle in the lamina propria of the bronchi.  The follicle bulges into the 
lumen of the bronchus, giving it a dome-like or nodular structure (Huang et al., 1990; Pabst 
and Tschernig, 2010).  The BALT is covered by specialized non-ciliated epithelium with 
cytoplasmic projections on its surfaces and infiltrations of lymphocytes within and beneath 
the epithelium (Huang et al., 1990).  In some species, e.g., rabbits, M cells specialized for 
antigen uptake are also present (Bienenstock and Johnston, 1976).  In pigs, the flattened 
epithelial cells covering the BALT are hypothesized to be M cell precursors (Huang et al., 
1990).  In pigs, antigenic exposure stimulates BALT development.  Thus, BALT is absent in 
germ-free pigs and found only in a proportion (30 to 50%) of healthy pigs (Pabst and Gehrke, 
1990).  Pigs infected with Actinobacillus pleuropneumoniae (Delventhal et al., 1992a, b) or 
Mycoplasma hyopneumoniae (Sarradell et al., 2003) had significantly more BALT structures 
compared to uninfected pigs.  Similar to tonsils, BALT has no afferent lymphatic ducts and 
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lymph is drained to the bronchial and tracheobronchial lymph nodes (Binenstock and 
McDermott, 2005; Pabst and Binns, 1995; Pabst and Tschering, 2002).   
 
CELLS ASSOCIATED WITH ANTIGEN PROCESSING AND PRESENTATION 
Dendritic cells          Dendritic cells are a heterogenous population of antigen-presenting cells 
that prime naïve T cells and/or B cells (Tizard, 2009).  Dendritic cells can be found in tonsil, 
spleen, lymph nodes, and blood (Jamin et al., 2006).  Although there is limited information 
on their distribution in the porcine respiratory tract, dendritic cells are abundant both below 
the basement membrane and within the tracheal epithelium (Bimczok et al., 2006).  Dendritic 
cells on the epithelial mucosa serve as immunological sentinels, i.e., they capture, internalize, 
process, and present antigen to naïve T cells.  Intraepithelial dendritic cells commonly have 
long dendrites extending toward the tracheal lumen that probably relate to this 
immunological surveillance function (Bimczok et al., 2006).  Dendritic cells play a role in T 
cell responses and homing characteristics (Saurer et al., 2007).  For example, interferon 
(IFN)-γ and interleukin (IL)-12 produced by dendritic cells stimulate T helper1 development 
(cell-mediated immunity), whereas IL-4, IL-10 and/or IL-13 favor a T helper 2 response 
(antibody formation) (Murphy, 2012; Raymond and Wilkie, 2004).  The effect of porcine 
dendritic cells on the differentiation of T regulatory cells has not been described 
(Summerfield and McCullough, 2009).   
 
Macrophages          Although found throughout the body, the lung is populated by two 
specific types of macrophages:  pulmonary alveolar macrophages (PAM) and pulmonary 
intravascular macrophages (PIM) (Winkler and Cheville, 1987).  Macrophages are antigen-
presenting cells, but they are less efficient at this function than dendritic cells (Tizard, 2009).  
Once loaded with antigen, alveolar macrophages cross the alveoli and pass to regional lymph 
nodes where they interact with T and B cells to initiate an immune response (Constant et al., 
2002).  In young pigs, PIMs number ~14,000 per mm3 of lung parenchyma and cover ~16% 
of the total lung capillary surface (Winkler and Cheville, 1987; Wrinkler, 1988).  Analogous 
to Kupffer cells in their function, PIMs serve to clear particles within the circulatory system 
and are a major component of the host's systemic defense mechanism (Staub, 1994).  PIMs 
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have less phagocytic activity than PAMs and little is known of their activity as antigen-
presenting cell (Chitko-McKown et al., 1991).   
 
CELLS ASSOCIATED WITH ANTIBODY PRODUCTION 
T cells          T cells are found in the peripheral circulation and lymphoid tissues throughout 
the body (Belz, 1998; Chianini et al., 2001) and facilitate antibody production by their 
interactions with B cells.  Porcine T cells are divided into two broad types based on the 
presence of αβ or γδ cell membrane receptors.  αβ T cells only recognize antigens presented 
by the major histocompatibility complex (MHC) molecule, whereas γδ T cell antigen 
recognition is not limited to MHC presentation (Charerntantanakul and Roth, 2007; Yang et 
al., 1996).  αβ T cells can be further divided into CD4+ and CD8+ subtypes.  CD4+ T cells are 
involved in antibody production and predominate during bacterial and parasitic infections.  
CD8+ T cells are involved in cell-mediated immune responses and primarily function in 
antiviral responses (Charerntantanakul and Roth, 2007).   
 
B cells          B cells, the progenitor of antibody-secreting plasma cells, are primarily found in 
the follicular areas of the lymphoid organs and infrequently in blood (Bianchi et al., 1992).  
Each mature B cell possesses external receptors that recognize and bind a specific antigen.  
Once bound, antigen is internalized, processed, and returned to the cell surface as a 
peptide:MHC complex molecule.  B cells are then activated by T helper cells that recognize 
the same epitope.  Activated B cells proliferate, and differentiate into antibody-secreting 
plasma cells and long-lived memory cells (Murphy, 2012).   
 
ANTIBODY PRODUCTION  
The adaptive immune response begins when antigens are recognized by dendritic cells, 
macrophages, or other antigen-presenting cells.  In the oral cavity and respiratory tract, these 
cells are located on the mucosal surfaces and in the organized lymphoid tissues (tonsils and 
BALT).  Although this response initiates both cell-mediated and humoral immune responses, 
our focus is on the latter.   
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The priming of naïve T cells in tonsil, BALT and lymph nodes by antigen-presenting cells in 
the presence of specific cytokines leads T cells to undergo clonal expansion and 
differentiation (Raymond and Wilkie, 2004).  In the presence of IL-4, IL-10, and/or IL-13, 
naïve T cells become T helper 2 cells, a CD4+ T cell subtype that promotes B cell 
proliferation and differentiation into antibody-secreting plasma cells (Murphy, 2012; 
Raymond and Wilkie, 2004).  The humoral immune response is initiated when a T helper 2 
cell recognizes the peptide:MHC complex molecule on the surface of a B cell ("linked 
recognition").  This event triggers the T helper 2 cell to synthesize B cell stimulatory 
molecules, including the T cell-bound CD40 ligand and secretory effector molecules IL-4, 
IL-5, and IL-6.  The interaction between the T cell CD40 ligand and the B cell CD40 
receptor, in the presence of IL-4, IL-5 and IL-6, stimulates B cell proliferation and 
differentiation into plasma cells or memory B cells (Murphy, 2012).   
 
Alternatively, B cells in the lamina propria of mucosal tissue can become IgA-secreting 
plasma cells without the participation of T helper cells by direct stimulation with B cell 
activating factor (BAFF), proliferation-inducing ligand (APRIL), and/or IL-17 (Doreau et al., 
2009; Lawson et al., 2011; Puga et al., 2010).  BAFF and APRIL are secreted by dendritic 
cells or epithelial cells, whereas IL-17 is a pro-inflammatory cytokine produced mainly by T 
helper 17 cells (Harrington et al., 2005; Lawson et al., 2011).  Porcine T helper 17 cells 
differentiate from CD4+ T cells in the presence of transforming growth factor-β (TGF-β) and 
IL-6/or IL-1β (Kiros et al, 2011; Stepanova et al., 2012).   
 
Plasma cells and memory B cells in tonsils can locomote to lacrimal glands, nasal mucosa, 
salivary glands, and bronchial submucosal glands (Brandtzaeg, 2007; Inoue, 1999) or migrate 
to the urogenital tract via the circulatory system (Bergquist et al., 1997; Czerkinsky et al., 
1994).  Plasma cells and memory B cells in BALT can locomote to the bronchial submucosal 
glands and bronchial lumen (Bienenstock and Clancy, 2005; Brandtzaeg, 2007).  Primed B 
cells can also migrate via draining lymphatic ducts to regional lymph nodes or, if they enter 
the blood stream, to the lung interstitium or remote mucosal tissues, e.g., gastrointestinal tract 
(Bienenstock and Clancy, 2005; Brandtzaeg, 2007; Saif, 1996).  The destination of these 
cells is determined by a homing mechanism based on complementary adhesion molecules on 
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the lymphocyte (integrin) and the high endothelial venules (addressin) in tandem with 
matched lymphocyte chemokine and tissue-specific chemokine receptors (Bourges et al., 
2007; Kunkel and Butcher, 2003).  For example, B cells and T cells that strongly express 
integrin α4β1 and chemokine subfamily CC receptor 10 (CCR10) on their surface 
preferentially "home" to tissues expressing addressin vascular cell adhesion molecule-1 
(VCAM-1) and chemokine subfamily CC ligand 28 (CCL28) (Bourges et al., 2004, 2007; 
Kunkel and Butcher, 2003; Xu et al., 2003).  In pigs, CCL28 is abundant in the pharyngeal 
tonsils and trachea, while VCAM-1 is found in the pharyngeal tonsils, lamina propria of the 
respiratory tract, and blood vessels in the nasal mucosa (Bourges et al., 2004, 2007; Meurens 
et al., 2006).   
 
DISTRIBUTION AND TRANSPORT OF ANTIBODY INTO ORO-RESPIRATORY 
SYSTEM 
Oro-respiratory secretions and tissues contain both systemic and locally-produced IgM, IgA, 
and IgG (Holmgren, 1973; Korsrud and Brandtzaeg, 1982; Martinez-Tello et al., 1968).  IgA 
predominates in upper respiratory tract secretions whereas IgG predominates in the lower 
respiratory tract (Morgan et al., 1980).  Depending on antibody isotype and anatomical 
location, antibody reaches mucosal secretions via passive diffusion or receptor-mediated 
transport.  Thus human parotid saliva contains >95% locally synthesized IgA, but whole 
saliva contains substantial amounts of IgG as a result of passive diffusion (Butler et al., 
1990). The poly IgA (pIgR) and neonatal Fc (FcRn) receptors transport IgA and IgG, 
respectively, across epithelial surfaces in a variety of species (Ravetch, 1997). 
 
Antibody in the oral cavity           
Systemic antibody, primarily IgG but also monomeric IgA, passively diffuses from the 
circulatory system into the oral cavity via one of three routes:  (1) from capillaries that lie 
beneath the epithelium of the oral mucosa; (2) via the gingival crevice, i.e., the space 
between the gingiva and the teeth, or (3) through the tight junctions between glandular cells 
of the salivary glands (Butler, 1967; Korsrud and Brandtzaeg, 1982; Naumova et al., 2013).  
Within the oral cavity, this antibody-rich transudate mixes with secretions from the major 
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and minor salivary glands (Challacombe and Shirlaw, 2005).   
Local production of antibody (IgM, IgA, IgG) occurs in plasma cells located in salivary 
glands, tonsils, and perhaps in duct-associated lymphoid tissue (Nair and Schroeder, 1986).  
Thus, either oral or Thiry-Vella loop inoculation of pigs with Escherichia coli strain 1261 or 
transmissible gastroenteritis virus resulted in the appearance of pathogen-specific IgM, IgA, 
and IgG-secreting plasma cells in mandibular and sublingual salivary glands (DeBuysscher 
and Berman, 1980; DeBuysscher and Dubois, 1978).  Mucosal IgA-or IgM- secreting plasma 
cells typically express a small "J chain" polypeptide (15 kDa) that promotes formation of 
polymeric IgA and pentameric IgM (Brandtzaeg, 1974; Korsrud and Brandtzaeg, 1979).  The 
transmembrane secretory (~80 kDa) component expressed on the basolateral surfaces of 
secretory epithelial cells acts as an epithelial receptor by binding the J chain of polymeric 
IgA or pentameric IgM  and selectively transporting them across mucosal epithelium and into 
mucosal secretions (Brandtzaeg, 1974; Brandtzaeg and Prydz, 1984; Kacskovic, 2004).  No 
binding of IgA or IgM was observed with epithelial cells lacking the secretory component 
(Brnadtzaeg and Prydz, 1984).  The anatomical distribution of the secretory component has 
not been described in pig salivary glands, but in human parotid and submandibular salivary 
glands, the secretory component is present in most acinar, intercalated, and striated duct 
cells, whereas the lining cells of excretory ducts lacks the secretory component (Korsrud and 
Brandtzaeg, 1982).   
 
In human palatine tonsils, detection of immunoglobulin associated with the tonsil epithelium 
suggested active immunoglobulin transport, although the presence of the secretory 
component in the tonsillar epithelium has not been reported (Brandtzaeg et al., 1978; Tang et 
al., 1995).  Whether or not active transport exists in tonsil, immunoglobulin, IgG in 
particular, is able to cross the tonsillar epithelium via passive diffusion and enter the tonsillar 
crypts (Brandtzaeg et al., 1978). 
 
Duct-associated lymphoid tissue (DALT) surrounding the ducts of minor salivary glands is 
thought to play a role in local production of secretory antibody.  This process occurs as a 
result of direct access to antigens via the short ducts of the minor salivary glands and remote 
antigenic stimulation as part of the common mucosal immune system (Nair and Schroeder, 
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1986).  Thus, minor salivary glands in humans produce approximately 30 to 35% of the total 
secretory IgA in oral secretions (whole saliva) (Crawford et al., 1975).  However, no 
structural or physiological evidence of DALT associated with minor salivary glands has been 
described in pigs (Liebler-Tenorio and Pabst, 2006).   
 
Antibody in the respiratory system           
Transudates containing systemic IgG and monomeric IgA passively diffuse from the 
capillaries, pass between respiratory epithelial cells, and reach the apical surface of the 
respiratory mucosal surfaces (Morgan et al., 1980; Ramphal et al., 1979).  Systemic IgG 
constitutes 78% of the total IgG in nasal secretions, 60% in trachea secretions, and 37% in 
bronchoalveolar secretions; the remainder consists of locally-produced IgG (Morgan et 
al.1980).  In contrast, systemic IgA constitutes 1 to 2.5% of the IgA in respiratory secretions 
with the remainder composed of locally-produced IgA.   
 
Local production of antibody occurs throughout the respiratory system, but the majority of 
plasma cells throughout the pig respiratory tract (with the exception of the lung parenchyma) 
produce IgA.  IgG-producing plasma cells are more numerous than IgM-secreting cells in the 
lung and nasal mucosa, but the reverse is true in the trachea and bronchus (Bradley et al., 
1976).  The relative concentration of IgA vs. IgG in tracheal and bronchoalveolar secretions 
corresponds to the proportion of IgA- or IgG- producing plasma cells in the tracheal mucosa 
and lung, respectively (Bradley et al., 1976; Morgan et al., 1980).  Thus, tracheal cultures 
synthesized more IgA than IgG, whereas the reverse was the case with lung tissue culture 
(Morgan et al., 1980).  In pigs, age may also affect the content of respiratory secretions.  
Thus, the ratio of IgA to IgG was significantly greater in the nasal, tracheal, and 
bronchoalveolar secretions from sows than 18- to 20-week-old pigs (Morgan et al., 1980).  
IgM-producing plasma cells are also present in the respiratory tract, but little is known 
regarding their contribution to respiratory secretions (Bradley et al., 1976).   
 
Two receptors are involved in the active transport of immunoglobulin into mucosal 
secretions of the respiratory tract.  Specifically, the secretory component facilitates transport 
of IgA and the neonatal Fc receptor (FcRn) transports IgG.  As previously discussed, the 
14 
 
 
 
secretory component is present in salivary glands, but it is also expressed in the nasal 
epithelium, mixed mucoserous glands beneath the nasal mucosa, and in the tracheobronchial 
lamina propria (Bourges et al., 2007).  The location of the secretory component corresponds 
to the distribution of IgA in the respiratory tract (Bradley et al., 1976).   
 
Neonatal Fc receptor (FcRn) is a 40 kDa major histocompatibility complex (MHC) class I-
related molecule that binds to the Fc-domain of IgG in a pH-dependent manner (Ghetie and 
Ward, 2000; Stirling et al., 2005).  FcRn is expressed in the epithelial cells of the ileum, 
jejunum, and duodenum of both neonatal and adult pigs (Stirling et al., 2005).  In the first 24 
to 36 hours after birth, neonatal piglets are able to absorbed antibodies in the dam's 
colostrum, but after gut closure FcRn receptors facilitate the transport of maternal IgG from 
the intestinal lumen into the piglet's circulatory system (Curtis and Bourne, 1971; Wangstrom 
et al., 2000). In the neonatal gut, IgG binding occurs at acidic pH and IgG release at neutral 
pH.  Thus, maternal IgG is bound by FcRn receptors on the apical surface of the epithelial 
cells at the lower pH found in the intestinal lumen.  Receptor-bound IgG then enters the cell 
by receptor-mediated endocytosis and is transported across the epithelial cell to the 
basolateral surface.  Exposure to physiological pH promotes the release of IgG into the 
circulation.  Once in the circulatory system, maternal antibody can cross into piglet’s 
respiratory tract and its secretions (Bradley et al., 1976; Nechvatalova et al., 2005, 2011; 
Stirling et al., 2005).  Thus, antigen-specific IgG and IgA were detected in bronchoalveolar 
secretions from piglets that ingested colostrum from sows vaccinated with an experimental 
antigen (Nechvatalova et al., 2011).   
 
In the pig respiratory tract, the specific mechanism by which IgG crosses the alveolar 
epithelial barrier is uncertain (Spiekermann et al., 2002).  However, FcRn has been detected 
in a variety of tissues, e.g., lung (bovine, human, mouse), liver (rodent, pig), kidney (pig), 
spleen (pig) and mammary gland (sheep, pig), and is postulated to modulate IgG transport at 
these sites (Blumberg et al., 1995; Ghetie and Ward, 2000; Kacskovics, 2004; Mayer et al., 
2002; Mayer et al., 2004; Schnulle and Hurley, 2003; Spiekermann et al., 2002; Stirling et 
al., 2005).  Although the specific mechanism by which IgG crosses the alveolar epithelial 
barrier has not been identified, FcRn-mediated IgG transport in the lower airway and alveoli 
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has been demonstrated in several species including rat, bovine, and cynomologus monkey 
(Bitonti et al., 2004; Kim and Malik, 2003; Mayer et al., 2004; Spiekermann et al., 2002).   
 
CONCLUSIONS 
The oro-respiratory tract is the site of entry for a tremendous number and variety of 
microorganisms.  These must be controlled by the host immune system, if health is to be 
maintained.  In particular, this discussion has focused on the means by which the humoral 
immune system responds to this exposure and populates the oro-respiratory tract with 
antibodies both from plasma cells in local tissues (salivary glands or mucosal epithelium) and 
from the circulatory system by passive diffusion.  A better understanding of the mechanics 
and dynamics of this process has the potential to provide insight into improved pig health and 
welfare through better vaccines and improved diagnostics.   
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Figure 1.  Major salivary glands, tonsils, and lymph nodes of the pig oral cavity and 
respiratory system.  1. pharyngeal tonsil  2. tubal tonsil  3. paraepiglottic 
tonsil  4. tonsil of the soft palate  5. lingual tonsil  6. parotid salivary gland  7. 
mandibular salivary gland  8. sublingual salivary gland  9. parotid lymph 
node  10. mandibular lymph node  11. retropharyngeal lymph node  12. 
tracheobronchial lymph node  (adapted with permission from Dyce et al., 
2010) 
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Figure 2.  Schematic of the processes resulting in the presence of antibodies on the 
mucosa and in mucosal secretions of the oro-respiratory system 
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SUMMARY 
In commercial swine populations, influenza A virus is an important component of the porcine 
respiratory disease complex (PRDC) and a pathogen with major economic impact.  
Previously, a commercial blocking ELISA (FlockChek™ Avian Influenza Virus MultiS-
Screen® Antibody Test Kit, IDEXX Laboratories, Inc., Westbrook, ME) designed to detect 
influenza A nucleoprotein (NP) antibodies in avian serum was shown to accurately detect NP 
antibodies in swine serum.  The purpose of present study was to determine whether this assay 
could detect NP antibodies in swine oral fluid samples.  Initially, the procedure for 
performing the NP blocking ELISA on oral fluid was modified from the serum testing 
protocol by changing sample dilution, sample volume, incubation time, and incubation 
temperature.  The detection of NP antibody was then evaluated using pen-based oral fluid 
samples (n = 182) from pigs inoculated with either influenza A virus subtype H1N1 or H3N2 
under experimental conditions and followed for 42 days post inoculation (DPI).  NP 
antibodies in oral fluid were detected from DPI 7 to 42 in all inoculated groups, i.e., the mean 
sample-to-negative (S/N) ratio of influenza-inoculated pigs was significantly different (p < 
0.0001) from uninoculated controls (unvaccinated or vaccinated-uninoculated groups) 
through this period.  Oral fluid vs. serum S/N ratios from the same pen showed a correlation 
of 0.796 (Pearson correlation coefficient, p < 0.0001).  The results showed that oral fluid 
samples from influenza virus-infected pigs contained detectable levels of NP antibodies for ≥ 
42 DPI.  Future research will be required to determine whether this approach could be used 
to monitor the circulation of influenza virus in commercial pig populations. 
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INTRODUCTION 
In swine, influenza A virus (IAV) infection is traditionally described as an acute, upper 
respiratory disease with high morbidity, low mortality, and respiratory signs characterized by 
coughing, nasal and/or ocular discharge, sneezing, dyspnea, hyperthermia, anorexia, lethargy 
and weight loss (Brown, 2000; Janke, 1998; Loeffen et al., 1999; Richt et al., 2006).  
Influenza virus infection in individual swine may be diagnosed on the basis of clinical signs 
and postmortem lesions (Van Reeth et al., 2012).  Biological samples (nasal swabs, 
bronchoalveolar lavage, serum, etc.) may be assayed by virus isolation, polymerase chain 
reaction (PCR), antibody-based assays, and other diagnostic techniques to support the 
diagnosis (Van Reeth et al., 2012). 
 
While suitable for diagnostic evaluations of clinical outbreaks, individual animal testing is 
not amenable to IAV surveillance in large commercial swine populations.  Alternatively, 
IAV infections have been detected using pen-based oral fluid samples collected under either 
experimental or field conditions and tested by reverse transcription (RT)-PCR (Detmer et al., 
2011; Romagosa et al., 2011; Ramirez et al., 2012).  Indeed, oral fluid-based diagnostics 
have been used extensively in human diagnostic medicine to detect and surveil a variety of 
infections, e.g., human immunodeficiency virus, mumps virus, measles virus, rubella virus, 
hepatitis C virus, and others (De Cock et al., 2004; De Cock et al., 2005; Holguín et al., 
2009; Perry et al., 1993). Thus, oral fluid sampling could provide a more convenient method 
for the surveillance of influenza virus infections in confined animal feeding operations. 
 
While PCR testing results reflect recent infection events, antibodies have the potential to 
inform regarding the history of infections in individuals and populations.  Cameron and 
Carman (2005) state that most serum ELISAs can be modified to detect antibodies in oral 
fluid samples by changing the procedure, e.g., increasing the sample volume, increasing the 
incubation time, changing conjugate concentration, and changing cut-off values.  A 
commercial ELISA designed to detect anti-influenza A nucleoprotein (NP) antibodies in 
avian serum was earlier shown to effectively detect NP antibodies in swine serum (Ciacci-
Zanella et al., 2010).  The purpose of present study was to determine whether diagnostic 
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levels of NP antibodies could also be detected in swine oral fluid specimens by adapting the 
serum ELISA protocol to the oral fluid matrix. 
 
MATERIALS AND METHODS 
Experimental design 
The detection of NP antibodies over time in pen-based oral fluid samples was evaluated in 
animals inoculated with influenza A subtype H1N1 or H3N2 and followed for 42 days post 
inoculation (DPI).  Weekly oral fluid samples (DPI 0, 7, 14, 21, 28, 35, 42) were assayed on 
an NP blocking ELISA (FlockChek™ Avian Influenza Virus MultiS-Screen® Antibody Test 
Kit, IDEXX Laboratories, Inc., Westbrook, ME) using a procedure for the detection of NP 
antibodies in oral fluid specimens.  Because vaccination against IAV is common in the field, 
vaccinated groups were included for the purpose of comparing and contrasting antibody 
responses.  The influenza antibody response measured in oral fluid specimens was 
statistically analyzed for the effect of treatment, time, and their interactions.  In addition, the 
association of NP antibodies in oral fluid specimens and NP antibodies in serum was 
evaluated by correlation analysis and the diagnostic performance of the oral fluid assay was 
evaluated using receiver operating characteristic (ROC) analysis.  The study was conducted 
under the approval (no. #11-09-6834-S) of the Iowa State University Institutional Animal 
Care and Use Committee and in compliance with the guidelines of the Institutional Biosafety 
Committee. 
 
Animals and treatments 
Animals (n = 82) in the study were obtained from one commercial farm with an inventory of 
approximately 600 breeding females.  Piglets were weaned, ear tagged, and placed in one 
room of a field quarantine facility at approximately 21 days of age.  Pigs were randomized to 
treatments (Table 1) by first assigning ear tag numbers to treatments and then blindly taking 
tags out of a container as the tags were applied.  Serum samples were collected on -42, -21, -
7, and 0 days post inoculation (DPI) and tested for IAV serum antibody to verify freedom 
from infection.  A randomly selected subset of 28 piglets was vaccinated on DPI -42 and -21 
with a multivalent, inactivated influenza vaccine (Flu-Sure® XP, Pfizer Animal Health, 
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Madison, NJ) following the instructions provided by the manufacturer.  Piglets remained in 
the field quarantine facility for 33 days.  On DPI -10, they were moved to the Iowa State 
University Livestock Infectious Disease Isolation Facility (LIDIF) and sorted into pens 
(Table 1).  On DPI 0, pigs were intratracheally administered 2 ml of a solution containing 
either A/Swine/OH/511445/2007 γ H1N1 (kindly provided by Dr. Amy Vincent, USDA, 
ARS, NADC, Ames IA) or A/Swine/Illinois/02907/2009 Cluster IV H3N2 (kindly provided 
by Dr. Marie Gramer, University of Minnesota, St. Paul, MN) at a concentration of 1 x 106.5 
tissue culture infective dose 50 (TCID50) per ml. 
 
Biological samples 
Serum collection          Blood samples (n = 574) were collected on DPI 0, 7, 14, 21, 28, 35, 
and 42 using a single-use blood collection system (Vacutainer®, Becton Dickinson, Franklin 
Lakes, NJ).  Blood samples were centrifuged at 1800 x g for 12 min at 4°C, and then serum 
was aliquoted into tubes for immediate serologic testing or storage at -20°C. 
 
Oral fluid collection          Oral fluid samples (n = 182) were collected daily from DPI -6 to 
42 from each pen of pigs by suspending a length of 1/2-inch (1.3cm), 3-strand, undyed, 
unbleached, 100% cotton rope (Web Rigging Supply, Inc., Lake Barrington, IL) from a 
bracket fixed to the side of each pen.  A routine was established whereby the rope was 
suspended in each pen for 30 minutes beginning at 7:00 a.m.  Consistent with normal pig 
behavior (Kittawornrat and Zimmerman, 2011), the pigs chewed on the rope during this time, 
depositing oral fluid on the rope in the process.  To extract the sample from the rope, the wet 
end of the rope was inserted into a plastic bag and severed from the dry portion of the rope.  
Then, while still within the bag, the wet rope was slowly passed through a hand wringer (BL-
38, Dyna-Jet Products, Overland Park, KS), causing oral fluid to accumulate in the bottom of 
the bag.  The bag was then pierced with a single-use needle and the contents drained into a 
50 ml tube (BD Falcon centrifuge tubes®, Two Oak Park, Bedford, MA).  To avoid 
contamination between samples, the wringer was cleaned with 70% alcohol and dried with 
paper towels between each use.  Operators wore personal protective equipment and changed 
latex gloves between processing each sample.  To exclude contamination between exposure 
groups, one individual collected oral fluid specimens from all the pens in an exposure group 
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(negative control, H1N1, H3N2) and processed the ropes in the rooms in which the exposure 
group was housed.  Immediately following collection, samples were refrigerated (4°C), 
processed by centrifugation at 9000 x g for 10 min at 4°C, and stored at -80°C until assayed. 
 
AI MultiS-Screen® Antibody Test Kit Influenza (NP ELISA) 
Quality control          Prior to testing, the plate washer passed the dispense precision and 
evacuation efficiency tests and the plate reader passed the absorbance plate test, empty 
carrier test, and liquid test described by the manufacturer (Bio Tek® Instruments Inc., 
Winooski, VT).  Negative and positive kit controls were run in duplicate on each plate.  As 
described by the manufacturer, valid assays required the mean negative control OD value to 
be ≥ 0.60 and the mean positive control S/N ratio to be ≤ 0.50. 
 
Serum samples          Serum samples were tested using a blocking NP ELISA licensed by the 
USDA for the detection of anti-influenza NP antibodies in avian serum.  This assay has also 
been shown to effectively detect NP antibodies in swine serum (Ciacci-Zanella et al., 2010).  
The NP ELISA is a blocking ELISA in which NP antibody in the sample binds to NP antigen 
coated to the bottom of the plate wells.  In the absence of NP antibody in the sample, 
unbound NP antigen reacts with the kit conjugate (monoclonal antibody), which then reacts 
with 3, 3’, 5, 5’- tetramethyl benzidine (TMB) substrate and develops color.  Thus, a lower 
intensity of color development reflects a greater concentration of NP antibody in the sample.  
Samples were tested according to the manufacturer’s instructions.  Plates were read at 650 
nm with an EL800 micro plate reader (Bio Tek® Instruments Inc., Winooski, VT) using 
GEN5™ software (Bio Tek® Instruments Inc.) Sample-to-negative (S/N) ratios were 
calculated for each sample according to the formula provided by the kit manufacturer 
(FlockChek™ Avian Influenza Virus MultiS-Screen® Antibody Test Kit, IDEXX 
Laboratories, Inc.).  A cut-off of S/N ≤ 0.60 was used to identify antibody-positive samples. 
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Oral fluid samples          Oral fluid samples were tested using the serum blocking NP ELISA, 
but the assay was performed using a protocol modified to account for the lower concentration 
of antibody in oral fluid.  Specific changes for this purpose included decreased sample 
dilution (undiluted vs. 1:10 in serum), increased sample volume (200 µl vs. 100 µl), and 
longer sample incubation (16 hr vs. one hr).  To quantify assay repeatability, the entire set of 
oral fluid samples was tested on each of three days. 
 
To perform the assay, undiluted oral fluid samples (200 µl) were added to wells of a 96-well 
plate coated with NP antigen and incubated for 16 hr at 22 °C in a refrigerated incubator.  
Undiluted negative and positive kit controls (100 µl) were run in duplicate and the results 
used to validate each plate.  In-house oral fluid negative and positive reference standards 
(200 µl) were run in duplicate on each plate to quantify variation between plates and kit lots.  
In-house negative reference standards were obtained from unvaccinated, uninoculated study 
pigs on DPI 42.  In-house positive reference standards were oral fluid samples collected over 
time from a barn that had tested for positive for influenza A virus using a PCR-based assay 
and provided three distinct levels of reactivity in the NP ELISA (Table 2).  After incubation, 
plates were washed 3 times with 350 μl of diluted 1:10 wash solution, 100 µl of NP antibody 
conjugate with horseradish peroxidase (HRP) was added, and plates were incubated for 30 
min.  Plates were then washed 3 times with 350 μl of diluted 1:10 wash solution, 100 μl of 
TMB substrate was added, and plates were incubated for 15 min.  Stop solution was then 
added to each well and plates were read immediately thereafter.  The reactions were 
measured as optical density (OD) at wavelength of 650 nm using a plate reader.  Sample-to-
negative (S/N) ratios were calculated for each sample using a formula provided by the kit 
manufacturer. 
 
Statistical analysis 
Statistical analyses were performed using commercial software (SAS® Version 9.2, SAS® 
Institute, Inc., Cary, NC).  ELISA S/N values were log10 transformed to meet the distribution 
requirements for valid statistical analyses and analyzed by repeated measures analysis of 
variance (ANOVA) using pen as the subject of repeated measures.  Vaccination (Y, N), 
inoculation (H1N1, H3N2, negative), DPI (0, 7, 14, 21, 28, 35, 42), and their interactions 
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were included as fixed effects, whereas day and plate were used as random effects.  Fixed 
and random effects were analyzed using the GLIMMIX procedure in SAS®.  Difference in 
treatment (vaccination, inoculation) groups least squares means were assessed using Tukey-
Kramer’s t-test.  The association of the pen level oral fluid S/N response and the mean serum 
S/N responses of pigs in the pen was assessed using Pearson’s correlation coefficient.  P-
values < 0.05 were considered statistically significant.  Diagnostic sensitivity, specificity, and 
associated 95% confidence intervals of the NP oral fluid ELISA were estimated by receiver 
operating characteristic (ROC) analysis (MedCalc® 9.2.1, MedCalc Software, Mariakerke, 
Belgium). 
 
RESULTS 
Oral fluid collection 
Although the volume of oral fluid collected was variable over time and between treatment 
groups (Figure 1), IAV infection had no detectable effect on the rate or volume of oral fluid 
collected.  Among 1,196 attempted oral fluid samplings, 1,187 (99.2%) samples were 
collected from -3 to 42 DPI (Figure 1).  The nine missing samples were from treatment 
groups UVH1 (1 pen on DPI 15 and 3 pens on DPI 16) and UVH3 (3 pens on DPI 4, one pen 
on DPI 5, and one pen on DPI 16).  Among the 1,187 samples, the overall mean oral fluid 
volume collected was 9.6 ml ± 3.8 (mean ± SD), with a range of 0.5 to 22.5 ml.  As can be 
seen in Figure 1, oral fluid volume increased over time concordant with the growth of the 
pigs. 
 
NP blocking ELISA responses 
Quality control parameters          Serum and oral fluid samples collected on DPI 0, 7, 14, 21, 
28, 35, and 42 were tested using the NP ELISA (Figures 2 and 3).  All plates met the 
manufacturer’s validity criteria, i.e., negative control OD values were ≥ 0.60 and the mean 
S/N of the two plate positive controls was ≤ 0.50 (Table 2).  OD responses from in-house 
oral fluid negative and positive reference standards showed consistent reactions across plates 
(Table 2).  Testing of the complete set of oral fluid samples on three separate days showed no 
statistical significantly differences in S/N response by testing day (p = 1.00). 
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Longitudinal S/N response          In serum samples (Figure 2), the least square mean S/N 
ratios of the six treatment groups at DPI 0 ranged from 0.69 to 0.86, with no significant 
difference in the S/N ratios among treatment groups (p = 0.113).  Using the cut-off of ≤ 0.60, 
7 of 28 vaccinated animals were serum antibody positive on the NP blocking ELISA on DPI 
0.  The remaining 75 pigs were NP antibody negative at DPI 0 and the 6 control pigs 
remained negative throughout the study.  For DPI 7 through 42, the S/N response in 
uninoculated groups differed significantly (p < 0.001) from inoculated groups.  Further 
analysis showed that inoculation (H1N1, H3N2, negative), vaccination (Y, N), and DPI (0, 7, 
14, 21, 28, 35, 42) all had significant effects on S/N ratios (p < 0.005).  Statistically 
significant two-way interactions were detected between vaccine status*DPI (p < 0.0001) and 
inoculation*DPI (p < 0.0001). 
 
In oral fluid samples (Figure 3), the mean S/N ratios of the six treatment groups at DPI 0 
ranged from 0.80 to 1.07, with no statistically significant difference in the S/N response 
among any of the six treatment groups (p = 0.286).  For DPI 7 through 42, no significant 
difference was detected in the S/N response between the two uninoculated groups (UVCTRL 
and VCTRL) or among the four inoculated groups (UVH1, VH1, UVH3, and VH3).  For the same 
period, the S/N response in uninoculated groups (UVCTRL and VCTRL) differed significantly (p 
< 0.001) from inoculated groups (UVH1, VH1, UVH3, and VH3).  On DPI 42, the last day of 
observation, the S/N ratio in vaccinated groups increased (became less positive), but the S/N 
ratios of all inoculated groups remained significantly different from uninoculated groups (p < 
0.05).  Further analysis showed that inoculation (H1N1, H3N2, negative), and DPI (0, 7, 14, 
21, 28, 35, 42) had significant effects on S/N values (p < 0.0001), but vaccination did not (p 
= 0.534).  Statistically significant two-way interactions were detected between vaccine 
status*DPI (p = 0.011) and inoculation*DPI (p < 0.0001). 
 
Serum vs. oral fluid responses          For the two uninoculated groups (UVCTRL and VCTRL), 
the overall mean serum and oral fluid S/N ratios for DPI 7 to 42 were 0.81 ± 0.13 (mean ± 
SD) and 1.05 ± 0.08 (mean ± SD).  Among the four inoculated groups (UVH1, VH1, UVH3, 
and VH3), the overall means for the same period were 0.35 ± 0.16 (mean ± SD) in serum and 
0.46 ± 0.09 (mean ± SD) in oral fluid.  Thus, S/N responses in oral fluid samples trended 
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higher than serum S/N responses.  A pen-level evaluation of the association between the pen 
level oral fluid S/N response and the mean serum S/N responses of pigs within the pen found 
a statistically significant association (p < 0.0001) between serum and oral fluid S/N responses 
and a Pearson’s correlation coefficient of 0.796 (Figure 4). 
 
Evaluation of test performance 
The diagnostic performance of the NP blocking ELISA was evaluated by receiver operating 
characteristic (ROC) curve analysis using the S/N results from 182 oral fluid samples.  This 
analysis produced an estimate of the area under the ROC curve (AUC) of 0.994 and the cut-
off values and associated sensitivity and specificity shown in Table 3 and Figure 5. 
 
DISCUSSION 
Influenza A virus is an important component of the porcine respiratory disease complex 
(PRDC) (Thacker et al., 2001) and a pathogen with major economic impacts on swine 
production.  Thus, Holtkamp (2007a, b) reported that influenza was among the three most 
costly infectious diseases in every stage of pig production in the United States, i.e., breeding, 
nursery, and finishing.  But whether the focus is swine production or public health, the 
challenge with IAV in swine populations is collecting a sufficient number of samples at the 
right time in the course of the infection to accurately describe the epidemic or endemic 
situation.  The detection of IAV has historically been based on testing individual pig nasal 
swab (virus detection) or serum (antibody detection) specimens.  While individual pig 
sampling is adequate for the diagnosis of clinical IAV infections, the collection of adequate 
numbers of individual pig samples is too costly and labor-intensive for routine influenza 
surveillance or large-scale ecological studies. 
 
The timing of sampling is critically important because negative PCR or virus isolation results 
may reflect the transient nature of the infection rather than recent events or the true status of 
the population.  Antibody provides a longer record of IAV infection, but the diagnostic 
performance of the current serum antibody assays, i.e., hemagglutination-inhibition (HI) or 
influenza subtype-specific ELISAs, has been problematic.  The HI response, based on the 
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binding of hemagglutinin (HA) protein on the viral surface and sialic acid receptors on 
erythrocytes, is affected by a number of factors, including dependence of the HI response on 
the degree of homology between the virus that stimulated IAV antibody production in the pig 
and the virus strain in the test (Barbé et al., 2009; Van Reeth et al., 2006), interference of 
antibodies against other IAV subtypes (Long et al., 2004), nonspecific inhibitors of IAV in 
swine serum, such as carbohydrate and sialic acid (Ryan et al., 1991), differences in the 
ability of IAVs to agglutinate erythrocytes (Levy and Wager, 1958), and differences in 
erythrocyte agglutinating properties among species and even among individual animals 
within species (Long et al., 2004; Schmidt and Lennette, 1970).  Individually or in 
combination, these variables can markedly affect HI serum antibody titers.  Importantly, 
deviations from the optimized combination of factors tend to produce false-negative results 
(Julkunen et al., 1985; Rossow et al., 2003).  Similarly, the current commercial swine H1N1 
and H3N2 ELISAs (IDEXX Laboratories, Inc.) possess low diagnostic sensitivity; 
presumably the result of differences between the antigen present in the assay and the viruses 
currently circulating in swine populations (Barbé et al., 2009; Long et al., 2004; Lorusso et 
al., 2011; Van Reeth et al., 2006; Yoon et al., 2004). 
 
As reviewed elsewhere (Prickett and Zimmerman, 2010), oral fluid samples have been shown 
to be a viable diagnostic specimen for the detection of a variety of pathogens and/or 
antibodies in a variety of species.  Pertinent to IAV, contemporary work under both 
experimental and field settings has shown that the virus can be detected in porcine oral fluid 
specimens using PCR-based assays (Detmer et al., 2011; Ramirez et al., 2012; Romagosa et 
al., 2011).  The current study was based on the detection of IAV NP antibody in porcine oral 
fluid specimens.  Nucleoprotein is a multifunctional protein associated with viral 
transcription, replication, and intracellular trafficking of the viral genome (Noda et al., 2006; 
Potela and Digard, 2002; Ye et al., 2006).  NP is highly conserved among IAVs and infection 
with any influenza subtype induces IAV-specific NP antibodies (de Boer et al., 1990; El 
Hefnawi et al., 2011; Wu et al., 2007).  This universal antibody response has tangible 
diagnostic benefits, e.g., a non-commercial NP blocking ELISA detected serum antibodies 
induced by IAV infections in humans, ferrets, swine, horses, chickens, ducks, guinea pigs, 
mice, and seals (de Boer et al., 1990).  The present study expanded upon earlier work by 
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demonstrating that porcine oral fluid specimens also contain diagnostically relevant levels of 
NP antibody, with no detectable difference between subtypes H1N1 or H3N2 in diagnostic 
sensitivity and specificity. 
 
These results are also in general agreement with reports of the detection of IAV antibodies in 
oral fluid specimens collected from humans (Brokstad et al., 1995a, b).  In humans, the 
presence of IAV antibodies in individual oral fluid specimens, as measured by an indirect 
ELISA, peaked at 8 to 9 days post vaccination (DPV) and declined thereafter (Brokstad et al., 
1995a).  The majority of IAV antibody through DPV 45 was IgA (Brokstad et al., 1995a), 
especially subclass IgA1 (Brokstad et al., 1995b).  In swine, there are no reports describing 
the kinetics of IAV antibodies in oral fluids, but the kinetics of both IgA and IgG have been 
reported in nasal lavage and bronchoalveolar lavage (BAL) specimens following inoculation 
with IAV subtypes H1N1 (Larsen et al., 2000) and H3N2 (Heinen et al., 2000).  Using a 
homologous indirect ELISA, IgA was determined to be the predominant antibody isotype in 
both sample types.  In BAL, IgA peaked at day 14 post inoculation and IgG peaked at day 21 
(Larsen et al. 2000).  Similar results for nasal lavage and BAL samples were reported in pigs 
infected with an H3N2 isolate.  Heinen et al. (2000) detected NP IgM and IgA using an 
antibody capture ELISA and IgG1 using an indirect double antibody sandwich assay.  In 
BAL, IgA was the predominant immunoglobulin.  Both IgA and IgG1 peaked at day 15, 
while IgM peaked at 7 days post inoculation (Heinen et al., 2000). 
 
Improved methods to surveil IAV infections in swine populations should continue to be of 
importance to swine producers and veterinarians because of IAV's zoonotic potential, 
disregard for inter-species barriers, and the public's view of the role swine play in the 
dispersion of the virus.  The results of this study support the conclusion that pen-based oral 
fluids could serve a role in the surveillance of IAV in swine populations by facilitating the 
collection and testing of large sample numbers in a welfare-friendly, worker-friendly, cost-
effective manner. 
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Table 1.    Experimental design 
 
Treatment group Inoculant Vaccination*
No. of 
pigs 
No. of 
pens 
Unvaccinated control (UVCTRL) None No 6 2 
Vaccinated control (VCTRL) None Yes 6 2 
Unvaccinated H1N1 (UVH1) H1N1 No 24 8 
Vaccinated H1N1  (VH1) H1N1 Yes 11 3 
Unvaccinated H3N2   (UVH3) H3N2 No 24 8 
Vaccinated H3N2   (VH3) H3N2 Yes 11 3 
 
*Vaccinated on DPI -42 and -21 with a multivalent, inactivated influenza vaccine (Flu-Sure® 
XP, Pfizer Animal Health, Madison, NJ, USA).
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Table 2.    Kit and in-house oral fluid control OD values from a commercial influenza ELISA* performed using a protocol 
modified to detect influenza virus nucleoprotein antibodies in swine oral fluids 
 
 Response (optical density) based on 9 plates (2 wells per plate)  
Controls Mean Range 
Standard 
Deviation 
95% Confidence 
Interval 
Kit antibody negative control (serum) 1.47 1.29 - 1.67 0.13 1.40, 1.53 
Kit antibody positive control (serum) 0.38 0.28 - 0.49 0.06 0.34, 0.41 
In-house antibody negative control (oral fluid) 1.53 1.30 - 1.71 0.11 1.48, 1.58 
In-house low antibody positive control (oral fluid)  0.82 0.72 - 0.93 0.06 0.79, 0.85 
In-house moderate antibody positive control (oral 
fluid) 
0.43 0.37 - 0.48 0.04 0.41, 0.45 
In-house high antibody positive control (oral fluid) 0.24 0.20 - 0.28 0.03 0.22, 0.25 
 
*FlockChek® Avian Influenza MultiS-Screen Antibody Test Kit, IDEXX Laboratories, Inc., Westbrook, Maine USA 
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Table 3.    S/N (sample/negative) cut-off and associated diagnostic sensitivity and 
specificity from a commercial influenza ELISA* performed using a protocol 
modified to detect influenza virus nucleoprotein antibodies in swine oral 
fluids 
 
 
*FlockChek® Avian Influenza MultiS-Screen Antibody Test Kit, IDEXX Laboratories, Inc., 
Westbrook, Maine USA 
  
S/N Cut-off Sensitivity (%) Specificity (%) 
≤ 0.87 100.0 (98.6, 100.0) 79.4 (71.2, 86.1) 
≤ 0.85 99.6 (97.9, 99.9) 84.1 (76.6, 90.0) 
≤ 0.80 99.2 (97.3, 99.9) 88.1 (88.1- 93.2) 
≤ 0.75 98.1 (95.6, 99.4) 92.1 (85.9, 96.1) 
≤ 0.70 97.0 (94.1, 98.7) 93.7 (87.9, 97.2) 
≤ 0.65 95.1 (91.7, 96.5) 96.8 (92.1, 99.1) 
≤ 0.60 90.5 (86.3, 97.3) 96.0 (91.0, 98.7) 
≤ 0.55 86.0 (81.2, 89.9) 99.2 (95.6, 99.9) 
≤ 0.52 81.1 (75.8, 85.6) 100.0 (97.1, 100.0) 
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Figure 1.  Oral fluid volume collected from day post inoculation -3 to 42 
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Figure 2.  Influenza virus serum antibody response by treatment group as measured 
using a commercial nucleoprotein blocking ELISA (mean ± SE) 
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Figure 3.  Influenza virus oral fluid antibody response by treatment group as measured 
using a commercial nucleoprotein blocking ELISA (mean ± SE) 
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Figure 4.  Correlation of ELISA sample-to-negative (S/N) responses between serum and 
oral fluid specimens 
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Figure 5.  Diagnostic performance of commercial nucleoprotein blocking ELISA 
adapted to oral fluid specimens as a function of sample-to-negative (S/N) cut 
off 
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CHAPTER 4.  KINETICS OF INFLUENZA A VIRUS NUCLEOPROTEIN 
ANTIBODY (IgM, IgA, AND IgG) IN SERUM AND ORAL FLUID SPECIMENS 
FROM PIGS INFECTED UNDER EXPERIMENTAL CONDITIONS 
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Accepted for publication in Vaccine 
 
ABSTRACT 
Indirect influenza A virus (IAV) nucleoprotein (NP) antibody ELISAs were used to compare 
the kinetics of the NP IgM, IgA, and IgG responses in serum and pen-based oral fluid 
samples collected from 82 pigs followed for 42 days post inoculation (DPI).  Treatment 
categories included vaccination (Y/N) and inoculation (Y/N) with contemporary H1N1 or 
H3N2 isolates.  Antibody ontogeny was markedly affected by vaccination status, but no 
significant differences were detected between H1N1 and H3N2 inoculated groups of the 
same vaccination status (Y/N) in IgM, IgA, or IgG responses.  Therefore, these data were 
combined in subsequent analyses.  The correlation between serum and oral fluid responses 
was evaluated using the pen-based oral fluid S/P response versus the mean serum S/P 
response of pigs within the pen.  IgM responses in serum and oral fluid were highly 
correlated in unvaccinated groups (r = 0.810), as were serum and oral fluid IgG responses in 
both unvaccinated (r = 0.839) and vaccinated (r = 0.856) groups.  In contrast, the correlation 
between serum and oral fluid IgA was weak (r ~ 0.3), regardless of vaccination status.  In 
general, vaccinated animals exhibited a suppressed IgM response and accelerated IgG 
response.  The results from this study demonstrated that NP-specific IgM, IgA, and IgG 
antibody were detectable in serum and oral fluid and their ontogeny was influenced by 
vaccination status, the time course of the infection, and specimen type. 
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INTRODUCTION 
Influenza A virus (IAV) is capable of infecting a wide variety of avian and mammalian 
species, including swine.  In swine, IAV infection may be subclinical or present acute 
respiratory or reproductive signs, e.g., stillborn piglets (Wesley et al., 2004) or abortion 
(Vannier et al., 1999).  In the field, respiratory signs and/or mortality rates are commonly 
exacerbated by the presence of common respiratory pathogens, e.g., porcine reproductive and 
respiratory syndrome virus (PRRSV), porcine circovirus type 2 (PCV-2), Mycoplasma 
hyopneumoniae, Actinobacillus pleuropneumoniae, and Bordetella bronchiseptica (Bochev 
et al., 2007; Choi et al., 2003).  Formerly considered a seasonal infection, IAV infection in 
contemporary swine herds circulates in all age groups throughout the year (Choi et al., 2003; 
Simon-Grifé et al., 2012), including piglets prior to weaning (Corzo et al., 2012). 
 
IAV is an enveloped RNA virus with a segmented, negative sense, single-stranded genome 
which, typical of RNA viruses, exhibits rapid genetic evolution via point mutations and 
genetic reassortment (van Reeth et al., 2012).  Influenza A virus subtype classification is 
based on the presence of two external surface proteins, hemagglutinin (HA) and 
neuraminidase (NA).  To date, 17 HAs and 10 NAs have been identified (Tong et al., 2012; 
Zhu et al., 2012).  Subtypes H1N1, H3N2 and H1N2 are common in pig populations around 
the world (Brown et al., 2000; Choi et al., 2002), but other subtypes are occasionally 
reported, e.g., H1N7 in England (Brown et al., 1994); H3N1 in the U.S. and Korea 
(Lekcharoensuk et al., 2006; Shin et al., 2006); H2N3 in the U.S. (Ma et al., 2007); H5N2 in 
Korea (Lee et al., 2009); H4N6 in Canada (Karasin et al., 2000); H7N2 in Korea (Kwon et 
al., 2011); and H9N2 in China (Xu et al., 2004). 
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Historically, IAV serology has relied on the hemagglutinin inhibition (HI) assay, which is 
based on the ability of anti-IAV antibodies to block the virus from agglutinating red blood 
cells.  However, the performance of the HI assay is affected by the interaction of a number of 
biological factors, including the degree of homology between the virus that stimulated IAV 
antibody production in the pig and the virus strain used in the HI test (Barbé et al., 2009; Van 
Reeth et al., 2006).  In particular, failure to achieve the optimal combination of factors tends 
to result in false-negatives (Julkunen et al., 1985; Rossow et al., 2003). 
 
Given that the IAVs circulating in swine populations are constantly evolving, a universal 
assay capable of detecting antibodies against any IAV subtype would be desirable.  Among 
the possibilities, nucleoprotein (NP) is considered a good candidate because it is a highly 
conserved internal protein (De Boer et al., 1990).  Previously it was shown that an NP 
blocking ELISA provided for the detection of IAV antibody in swine regardless of subtype 
(Ciacci-Zanella et al, 2010)  Later work expanded on the initial observations in pigs by 
showing that NP antibody in serum correlated with the detection of NP antibody in oral 
fluids (Panyasing et al., 2012).  The purpose of the present study was to expand on the earlier 
reports by describing the ontogeny of the NP-specific IgM, IgA, and IgG responses in serum 
and oral fluids from vaccinated and non-vaccinated pigs inoculated with IAV H1N1 or 
H3N2. 
 
MATERIALS AND METHODS 
Experimental Design 
Immunoglobulin M (IgM), A (IgA), and G (IgG) responses against influenza A virus (IAV) 
nucleoprotein (NP) were evaluated in serum and oral fluid specimens collected for 42 days 
post inoculation (DPI) from pigs [unvaccinated (UV) or vaccinated (V)] inoculated with IAV 
subtypes H1N1 or H3N2.  Serum and oral fluid NP antibody (IgM, IgA, IgG) kinetics were 
analyzed in the context of vaccination status (Y/N), inoculation status (Y/N), IAV inoculum 
(H1N1 or H3N2), time post-inoculation, and their interactions.  The ability of the serum and 
oral fluid NP ELISAs to discriminate between negative and inoculated pigs was evaluated 
using receiver operating characteristic (ROC) analyses. 
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Animals and treatments 
The study was conducted with the approval of the Iowa State University Office for 
Responsible Research (#11-09-6834-S).  Animals (n = 82) in the study were obtained from 
one commercial farm with an inventory of approximately 600 breeding females.  Piglets were 
weaned, ear tagged, and placed in one room of a field quarantine facility at approximately 21 
days of age (DPI -43).  Pigs were randomized to one of six treatments by first assigning ear 
tag numbers to treatments and then blindly taking tags from a container as the tags were 
applied.  To verify freedom from IAV infection, serum samples were collected on  -42, -21, -
7, and 0 days post inoculation (DPI) and tested for IAV serum antibody using a commercial 
NP blocking ELISA (IDEXX Influenza A Ab Test, IDEXX Laboratories, Inc., Westbrook, 
ME).  A randomly selected subset of 28 piglets was vaccinated on DPI -42 and -21 with a 
multivalent, inactivated influenza vaccine (Flusure®XP, Pfizer Animal Health, Madison, NJ). 
 
On DPI -10, animals were moved to the Iowa State University Livestock Infectious Disease 
Isolation Facility (LIDIF) and placed in treatment groups:  (1) unvaccinated, uninoculated 
controls (UVCTRL, 2 pens of 3 pigs);  (2) vaccinated, uninoculated controls (VCTRL, 2 pens of 
3 pigs);  (3) unvaccinated, inoculated with H1N1 (UVH1, 8 pens of 3 pigs);  (4) vaccinated, 
inoculated with H1N1 (VH1, 3 pens of 3 or 4 pigs);  (5) unvaccinated, inoculated with H3N2 
(UVH3, 8 pens of 3 pigs); and  (6) vaccinated, inoculated with H3N2 (VH3, 3 pens of 3 or 4 
pigs). 
 
On DPI 0, pigs were intratracheally administered 2 ml of a solution containing either 
A/Swine/OH/511445/2007 γ H1N1 (kindly provided by Dr. Amy Vincent, USDA, ARS, 
NADC, Ames IA) or A/Swine/Illinois/02907/2009 Cluster IV H3N2 (kindly provided by Dr. 
Marie Gramer, University of Minnesota, St. Paul, MN) at a concentration of 1 x 106.5 tissue 
culture infective dose 50 (TCID50) per ml, as designated for treatment groups.  
 
Biological samples 
Serum samples were collected from 82 pigs on DPIs -42, -21, -7, 0, 7, 14, 21, 28, 35, and 42 
for a total of 819 samples.  Serum samples were processed by centrifugation at 1500 x g for 
12 min at 4˚C, after which serum was aliquoted into tubes and stored at -20˚C.  Pen-based 
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oral fluid samples were collected from 26 pens daily from DPI 0 to 42 for a total of 510 
samples.  Oral fluid samples were processed by centrifugation at 9000 x g for 10 min at 4˚C, 
after which samples were aliquoted into tubes and stored at -80˚C. 
 
Serum NP antibody isotype-specific indirect ELISAs 
Serum samples were assayed for IAV-specific antibody isotypes using plates and reagents, 
i.e., sample diluent, substrate, stop solution, and wash solution, from a commercial NP 
blocking ELISA kit (IDEXX Influenza A Ab Test).  The manufacturer's protocol was 
modified, as described below, to detect IgM, IgA, or IgG. 
 
Serum ELISA plate controls          Negative and isotype-specific positive control sera were 
run in duplicate on each plate.  Controls were used to validate plate performance and to 
calculate sample-to-positive (S/P) ratios.  The negative control consisted of a pool of serum 
collected on DPI 42 from the 6 negative control (UVCTRL) pigs diluted 1:100 (IgM), 1:50 
(IgA) and 1:800 (IgG) with sample diluent.  Positive controls for serum IgM, IgA, and IgG 
assays were obtained from pooled serum collected on DPI 7 (IgM), 14 (IgA), and 42 (IgG) 
from the 24 unvaccinated pigs inoculated with IAV subtype H1N1 (UVH1).  Positive control 
sera were diluted 1:100 (IgM), 1:10 (IgA), and 1:400 (IgG) with sample diluent for isotype-
specific assays.  Optical density (OD) values of negative control sera for IgM-, IgA-, and 
IgG-specific ELISA assays were 0.2, 0.2, and 0.4 respectively; whereas OD values of 
positive control sera for IgM, IgA and IgG assays were 0.8, 0.8, and 1.0.  Controls were 
prepared for use, aliquoted into 2 ml cryovials, and stored at -20 ˚C. 
 
Preparation of conjugates          The appropriate dilution of horseradish peroxidase (HRP)-
conjugated goat anti-pig IgM (A100-100P, Bethyl laboratories Inc., Montgomery, TX), IgA 
(A100-102P, Bethyl laboratories Inc.), or IgGFC (A100-104P, Bethyl laboratories, Inc.) was 
calculated for each lot of ELISA plates to standardize the strength of the reaction and ensure 
the reproducibility of results.  This was achieved by determining the dilution of anti-pig IgM, 
IgA, or IgG conjugate that matched the OD values of negative and positive controls for each 
assay (described in the previous paragraph).  Conjugate concentrations were prepared using a 
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commercial conjugate diluent (IDEXX PRRS X3 Ab Test, IDEXX Laboratories, Westbrook, 
ME) and stirred for 48 hours at 4˚C before use. 
 
Serum NP antibody isotype-specific protocols          For the detection of IgM antibody, 
serum samples were diluted 1:50 (5 µl of sample with 245 µl of sample diluent), after which 
plates were loaded with 100 µl of diluted samples and pre-diluted (1:100) negative and 
positive controls (in duplicate).  Plates were incubated at 37˚C for 2h and then washed 3 
times with 400 µl of ELISA kit wash solution diluted 1:10 with deionized water.  Next, 100 
µl of HRP-conjugated goat anti-pig IgM antibody diluted 1:8,000 was added to each well and 
plates incubated at 37 ˚C for 1h.  Plates were washed 3 times with 400 µl of wash solution, 
and 100 µl of 3, 3’, 5, 5’- tetramethyl benzidine (TMB) substrate was added.  Plates were 
incubated at room temperature for 15 min, 100 µl of stop solution were added to stop the 
reaction, and plates were read immediately thereafter.  Reactions were measured as OD value 
at a wavelength of 650 nm using an ELISA plate reader (Biotek® Instruments Inc., Winooski, 
VT) operated with commercial software (GEN5™, Biotek® Instruments Inc.) 
 
The indirect ELISA protocol used for the detection of serum NP-specific IgG and IgA 
followed the IgM protocol with minor exceptions.  Specifically, serum samples for the IgG 
assay were diluted 1:50 (5 µl of a sample with 245 µl of sample diluent) and HRP-conjugated 
goat-anti-pig IgGFC antibody was diluted 1:10,000; whereas serum samples for the IgA assay 
were diluted 1:10 (20 µl of a sample with 180 µl of sample diluent) and HRP-conjugated 
goat anti-pig IgA was diluted 1:2,000. 
 
Oral fluid NP antibody isotype-specific indirect ELISAs 
Preparation of ELISA plates          Oral fluid samples were assayed on ELISA plates 
manually coated with commercially produced NP antigen derived from a human IAV isolate 
(A/Puerto Rico/8/34/Mount Sinai (H1N1) segment 5) cloned into a baculovirus expression 
system (Cat no. IMR-274, Imgenex© Corporation, San Diego, CA).  In brief, 96-well 
microtitration plates (Cat no. 446469, Fisher Scientific, Hanover, Illinois USA) were coated 
with one µg of NP antigen (Imgenex© Corporation) per well by adding 100 µl of a 1:100 
dilution of NP antigen in 0.05 M carbonate-bicarbonate buffer (C3041, Sigma-Aldrich, St. 
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Louis, MI).  Coated plates were then incubated at 25˚C overnight.  After incubation, plates 
were washed 3 times with 400 µl of ELISA kit wash solution diluted 1:10 with deionized 
water.  Next, 300 µl of 1% bovine serum albumin (BSA) blocking buffer [50 g of sucrose 
(Sigma-Aldrich) , 2.5 g of dextran (Sigma-Aldrich), 25 ml of glycerol (Sigma-Aldrich), 500 
µl of procline (Sigma-Aldrich), 5 g of BSA (Cat no. 001-000-162 Jackson, ImmunoResearch 
Laboratories, West Grove, PA) plus 1X PBS (Sigma-Aldrich) to total 0.5 liter] were added 
and incubated at 25˚C for 2 h.  The blocking buffer was removed without washing.  Plates 
were then dried at 37˚C for 2 h and stored at 4˚C in a seal bag with desiccant packs until 
used.  To evaluate the consistency of the coating process, each lot of NP-coated plates was 
evaluated by testing one well of each plate with one antibody-positive sample and calculating 
the coefficient of variation (standard deviation:mean) of the OD responses.  Plate lots with a 
coefficient of variation ≥10% were rejected. 
 
Preparation of conjugates          Secondary antibody conjugates for the oral fluid NP 
antibody isotype-specific indirect ELISAs were prepared as described for the serum ELISAs. 
 
Oral fluid ELISA plate controls            Negative and positive controls were run in duplicate 
on each plate.  The negative control consisted of a pool of serum collected on DPI 42 from 
the 6 negative control (UVCTRL) pigs diluted 1:400, 1:10, and 1:200 with ELISA kit sample 
diluent for IgM, IgA, and IgG assays, respectively.  The OD values of negative controls were 
0.2, 0.2, and 0.3 for oral fluid IgM, IgA, and IgG assays.  Positive controls for oral fluid 
assays were obtained from pooled serum collected on DPI 7 (IgM), 14 (IgA), and 42 (IgG) 
from the 24 unvaccinated pigs inoculated with IAV subtype H1N1 (UVH1) and diluted 1:300 
(IgM), 1:5 (IgA), and 1:600 (IgG) with ELISA kit sample diluent for the isotype-specific 
ELISAs.  The OD values of the positive controls oral fluid for IgM, IgA, and IgG assays 
were 1.2, 1.4, and 1.2, respectively.  Controls were prepared for use, aliquoted into 2 ml 
cryovials, and stored at -20 ˚C. 
 
Oral fluid NP antibody isotype-specific protocols          The oral fluid NP antibody isotype-
specific assay protocols used the same sample dilution, sample volume, incubation time, and 
incubation temperature, but differed in conjugate concentrations.  The reagents used in the 
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assays, i.e., substrate, stop solution, and wash solution, were from a commercial NP blocking 
ELISA kit (IDEXX Influenza A Ab Test).  To perform the assays, 200 µl of undiluted oral 
fluid specimens and 100 µl of pre-diluted negative and positive controls (in duplicate) were 
added to the wells of an NP-coated plate and incubated at 4˚C for 16 h.  After incubation, 
plates were washed 3 times with 400 µl of ELISA kit wash solution diluted 1:10 with 
deionized water.  For the detection of IgM antibody, 100 µl of HRP-conjugated goat anti-pig 
IgM antibody diluted 1:2,000 was added to each well.  For the detection of IgA or IgG 
antibody, HRP-conjugated goat anti-pig IgA antibody diluted 1:2000 or HRP-conjugate goat 
anti-pig IgGFC antibody diluted 1:1,500 was used.  After adding conjugate, plates were 
incubated at 37˚C for 1h.  Plates were then washed 3 times with 400 µl of wash solution, 100 
µl of TMB substrate was added, and plates were incubated at room temperature for 15 min.  
100 µl of stop solution was then added and plates were read immediately thereafter.  
Reactions were measured as OD value at a wavelength of 650 nm using an ELISA plate 
reader (Biotek® Instruments Inc) operated with commercial software (GEN5™, Biotek® 
Instruments Inc.). 
 
S/P ratio calculation 
Serum and oral fluid IgM, IgA, and IgG responses were represented as sample-to-positive 
(S/P) ratios calculated using the following formula. 
 
S/P ratio =  
       (sample OD – negative control mean) 
_______________________________________________________________________________________________________________ 
(positive control mean – negative control mean) 
 
Analysis 
The effects of treatment (vaccination and inoculation status) on antibody isotype-specific S/P 
responses over time were analyzed by repeated measures analysis of variance (ANOVA) 
using NP ELISA S/P ratios from weekly serum samples and oral fluid samples collected on 
DPI 0 to 14, 17, 21, 28, 35, and 42 (SAS® Institute, Inc., Cary, NC).  Differences in 
treatment group least squares means were assessed using the Tukey-Kramer test.  The 
association of the pen-level oral fluid S/P response and the mean of the serum S/P responses 
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of pigs in the pen was assessed using Pearson’s correlation coefficient.  P-values < 0.05 were 
considered statistically significant. 
 
The performance of serum and oral fluid NP isotype-specific ELISAs was evaluated by first 
establishing optimum S/P cut-offs and then calculating the percent positives within treatment 
groups over time.  The optimum cut-off was determined using receiver operating 
characteristic (ROC) analysis (MedCalc® Version 12.2.1.0, MedCalc Software, Mariakerke, 
Belgium).  Known negatives were restricted to group UVCTRL (DPI 0 to 42) and known 
positives to group UVH1H3.  Within group UVH1H3, serum IgM positives were defined as 
samples from DPI 7; IgA positives as samples from DPI 14, and IgG positives as samples 
from DPIs 14, 21, 28, 35, and 42.  Oral fluid positives were from group UVH1H3 on DPIs 5 
through 11 (IgM), DPIs 6 through 14, 17, 21, 28, 35, and 42 (IgA), and DPIs 8 through 14, 
17, 21, 28, 35, and 42 (IgG). 
 
RESULTS 
To verify freedom from IAV infection prior to inoculation, serum samples collected on DPI -
42, -21, -7, and 0 days were tested for IAV serum antibody using a commercial NP blocking 
ELISA (IDEXX Influenza A Ab Test, IDEXX Laboratories, Inc.).  No NP-specific serum 
antibody was detected at DPI -42, -21, -7 or 0 in any of the 54 unvaccinated pigs.  Among 
vaccinated pigs, 4 of 28 and 9 of 28 vaccinated pigs were NP antibody positive at DPI -7 and 
0, respectively (data not shown). 
 
Quantitative responses of NP isotype-specific antibody ELISAs 
NP-specific serum antibody          Quantitative IgM, IgA, and IgG responses (S/P ratios) in 
serum by time post inoculation are given in Figure 1.  Within vaccination status (UV or V), 
repeated measures ANOVA found no significant differences (p < 0.05) over time in IgM, 
IgA, and IgG responses between H1N1 and H3N2 inoculated groups.  Therefore, the results 
were combined into groups UVH1H3 and VH1H3 for the remainder of the analyses. 
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The NP-specific IgM S/P ratios gradually increased over time in all groups prior to 
inoculation (DPI -42 to 0).  Compared to DPI -42, IgM S/P ratios were significantly greater 
at DPI -21, -7 and 0 in all treatment groups (p < 0.0001).  Following inoculation, an NP-
specific IgM antibody response was only detected in group UVH1H3.  This response was 
significantly different from groups UVCTRL, VCTRL, and VH1H3 at DPI 7 (p < 0.0001). 
Similar to IgM, the NP-specific IgA S/P ratios gradually increased over time in all groups 
prior to inoculation (DPI -42 to 0).  Following inoculation, no statistically significant 
difference in the NP-specific IgA antibody was detected among the 4 treatment groups 
(UVCTRL, VCTRL, UVH1H3, and VH1H3), except at DPI 14 when the IgA response in group 
UVH1H3 was significantly greater than UVCTRL, VCTRL, and VH1H3 (Figure 1). 
 
In contrast to IgM and IgA, no NP-specific IgG S/P response was detected in unvaccinated 
groups (UVCTRL and UVH1H3) prior to inoculation (DPI -42 to 0).  Following inoculation, the 
IgG response in group UVH1H3 was greater than UVCTRL at DPI 14 (p < 0.0001), achieving its 
maximum response at DPI 35 (Figure 1).  Vaccination produced an NP-specific serum S/P 
IgG response in vaccinates at DPIs -7 and 0 (Figure 1) that differed from unvaccinated pigs 
(p < 0.0015).  The mean IgG S/P ratio in VCTRL trended to decline after DPI -7, but remained 
greater than UVCTRL (p < 0.05) through DPI 35.  In VH1H3, the IgG response reached a 
maximum response at DPI 14 and remained stable through the end of study.  A comparison 
of VH1H3 and UVH1H3 found no differences between these groups from DPI 21 to 42. 
 
NP-specific oral fluid antibody          Quantitative IgM, IgA, and IgG responses in oral fluid 
by time post inoculation are given in Figure 2.  Within vaccination status (UV or V), repeated 
measures ANOVA found no significant differences over time in IgM, IgA, and IgG 
responses between H1N1 and H3N2 inoculated groups.  Therefore, the results were 
combined into groups UVH1H3 and VH1H3 for the remainder of the analyses. 
 
The NP-specific IgM S/P ratio in UVH1H3 was significantly different (p < 0.01) from groups 
UVCTRL, VCTRL, and VH1H3 at DPI 5 to 11 (p < 0.05).  The IgM response in UVH1H3 peaked at 
DPI 8, after which it rapidly declined.  The analysis found that the IgA S/P ratios in groups 
UVH1H3 and VH1H3 were significantly different (p < 0.001) from groups UVCTRL and VCTRL on 
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DPI 6 and remained so through DPI 42.  The NP-specific IgG S/P responses in UVH1H3 and 
VH1H3 were significantly different from groups UVCTRL and VCTRL at DPI 8 (p < 0.001) and 
remained so through DPI 42.  The maximum IgG response in both UVH1H3 and VH1H3 
occurred at DPI 10. 
 
Qualitative responses of NP isotype-specific antibody ELISAs 
ROC analyses of IgM, IgA, and IgG NP ELISAs established the optimum S/P cut-offs for 
serum at 0.84 (IgM), 0.75 (IgA) and 0.60 (IgG) and for oral fluid at 0.50 (IgM), 0.60 (IgA), 
and 0.60 (IgG).  These cut-offs were used to calculate the percent of serum and oral fluid 
positive samples by DPI, as shown in Tables 1 and 2. 
 
NP-specific serum antibody          Known negative serum samples included 60 samples 
collected between DPI -42 and 42 from the 6 pigs in group UVCTRL and 192 serum samples 
collected between DPI -42 to 0 from the 48 pigs in group UVH1H3.  Based on the cut-offs 
established in the ROC analysis, 98.4%, 97.2% and 100% of these samples were ELISA 
negative for IgM, IgA, and IgG, respectively.  Specifically, the IgM ELISA produced 4 false 
positive results in UVH1H3 (2 each on DPI -7 and 0).  The IgA ELISA produced 2 false 
positive results in UVCTRL (one each on DPIs 28 and 42) and 5 false positive results in 
UVH1H3 (2 on DPI-7 and 3 on DPI 0). 
 
The proportion of ELISA serum antibody-positive pigs varied by DPI, treatment group, and 
antibody isotype.  A small number of IgM and/or IgA, seropositive animals were detected 
among vaccinates (VCTRL and VH1H3) on DPI -21, -7, and 0, i.e., prior to IAV inoculation.  In 
contrast, vaccination produced a detectable NP-specific serum IgG response in in ≥40% of 
vaccinates at DPIs -7 and 0 (Table 1). 
 
Following inoculation, the IgM and IgA serum responses in group UVH1H3 were both more 
robust and of longer duration than VH1H3, but in neither case was a response detected in all 
animals (Table1).  That is, 47 of 48 serum samples from UVH1H3 were IgM positive whereas 
only 1of 22 from VH1H3 were positive at DPI 7.  Similarly, 24 of 28 were IgA positive in 
group UVH1H3 whereas only 4 of 22 were positive in group VH1H3 at DPI 14.  In contrast, IgG 
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was detected in 100% of pigs in group VH1H3 by DPI 7 and 100% of pigs in group UVH1H3 by 
DPI 14 (Table 1) and both groups remained positive through DPI 42. 
 
NP-specific oral fluid antibody          Known negative oral fluid samples included 40 oral 
fluid samples collected between 0 and 42 from the 2 pens in group UVCTRL.  All of these 
samples were ELISA negative for IgM, IgA, and IgG (Table 2).  Likewise, no NP-specific 
IgM, IgA or IgG was detected in the 40 oral fluid samples collected from group VCTRL 
between DPI 0 through 42.  However, one of six samples from group VH1H3 was positive for 
IgM on DPI 0, although these 6 samples were negative for IgA and IgG. 
 
Following inoculation, the IgM response in UVH1H3 was more robust and of longer duration 
than VH1H3 (Table 2).  In UVH1H3, an NP-specific IgM was first detected on DPI 1 (2 of 15 
positives).  This response peaked (100%) on DPIs 7, 8, and 9, with the last positive sample 
on DPI 21 (Table 2).  NP-specific oral fluid IgA was first detected in VH1H3 and UVH1H3 at 
DPI 1 (2 of 6 pens) and DPI 3 (3 of 14 pens), respectively.  Both groups were 100% positive 
by DPI 7 and remained so for the remainder of the study.  All samples from groups UVH1H3 
and VH1H3 were positive for NP-specific IgG oral fluid antibody on DPIs 9 through 42. 
 
Correlation of serum and oral fluid NP isotype-specific antibody responses 
A pen-level evaluation of the association between serum and oral fluid antibody isotype 
responses was performed using the mean of the serum S/P ratios of pigs within the pen 
versus the pen-based oral fluid S/P ratios (Figure 3).  IgM responses in serum and oral fluid 
were highly correlated in unvaccinated groups (UVCTRL and UVH1H3) (p < 0.0001, r = 0.810).  
Likewise, serum and oral fluid IgG responses in unvaccinated groups (UVCTRL and UVH1H3, r 
= 0.839) and vaccinated groups (VCTRL and VH1H3, r = 0.856) were statistically significant (p 
< 0.0001).  No association between serum and oral fluid antibody responses was found for 
IgM antibody in vaccinated groups (VCTRL and VH1H3) or for IgA antibody in either 
unvaccinated (UVCTRL and UVH1H3) or vaccinated groups (VCTRL and VH1H3). 
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DISCUSSION 
The purpose of this study was to describe the kinetics of the NP-specific IgM, IgA, and IgG 
responses in serum and oral fluid specimens from IAV-vaccinated and non-vaccinated pigs 
for 42 days following inoculation with IAV H1N1 and H3N2 subtypes.  The NP protein, 
present in all IAV subtypes, is a major component of the ribonucleoprotein complex (El 
Hefnawi et al., 2011) and a multifunctional, highly-conserved protein with critical roles in 
IAV replication (Lamb et al., 2001; Portela and Digard, 2002; Shu et al., 1993).  Infection 
with IAV stimulates both cell-mediated and humoral immune responses against NP, 
including the production of NP-specific cytotoxic T lymphocytes (Braciale et al., 1977; 
Carragher et al., 2008; Hillaire et al., 2011; Yewdell et al., 2008) and NP-specific IgM, IgA, 
and IgG antibodies (Carragher et al., 2008; de Boer et al., 1990; Heinen et al., 2000; Heinen 
et al., 2001; Kim et al., 2006).  Subsequent to infection, NP antibody is present in serum (de 
Boer et al., 1990, Nelson et al., 2001; Sullivan et al., 2009; Ciacci-Zanella et all., 2010) and 
other sample matrices, e.g., bronchoalveolar lavage (BAL) (Heinen et al., 2000), nasal wash 
(Heinen et al., 2000), and oral fluid (Panyasing et al., 2012). 
 
Because NP is highly conserved among IAV subtypes, it has been possible to develop 
antibody assays capable of detecting IAV infections across species.  Thus, anti-NP serum 
antibody was detected in chickens, ducks, ferrets, guinea pigs, horses, humans, mice, seals, 
and pigs using a double-antibody sandwich blocking ELISA (de Boer et al., 1990).  
Likewise, anti-NP serum antibody was detected in a variety of marine mammals, including 
beluga (Delphinapterus leucas) and ringed seals (Phoca hispida) using a competitive ELISA 
(Nielson et al., 2001) and in raccoons and mallards using a blocking ELISA (Sullivan et al., 
2009).  At present, a single commercial NP antibody ELISA (IDEXX Influenza A Ab Test) 
is available for the detection of NP antibody in chickens, turkeys, ducks, ostriches, geese, 
pigs, horses, dogs, cats, and zoo animals. 
IAV IgM has been reported in various specimen types, including serum, bronchoalveolar 
lavage, and nasal wash samples (Carragher et al., 2008; Heinen et al., 2000; Heinen et al., 
2001).   IgM is important because it neutralizes IAV early in the course of infection and 
before other antibody isotypes appear (Ochsenbein et al., 1999).  In mice inoculated with 
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IAV, IgM antibody-secreting cells preceded the appearance of IgG or IgA secreting cells in 
the lung, spleen, and blood (Jones and Ada., 1986).  In contrast, mice unable to produce IgM 
but capable of producing other antibody isotypes exhibited higher pulmonary IAV titers 
compared to wild-type mice (Kopf et al., 2002).  IgM appears rapidly because it can be 
produced by B1 cells in the absence of T helper cells via the T-independent pathway, as well 
as antigen-specific B-cells (B2 cells) via the T-dependent pathway (Baumgarth et al., 1999; 
Jones et al., 2012).  Consistent with prior research, IgM preceded the detection of IgA and 
IgG in both serum and oral fluids in the present study (Tables 1, 2). 
 
Because of its rapid appearance, it has been suggested that the detection of IgM antibody 
might be considered indicative of recent IAV infection (Buchner et al., 1977; Jones et al., 
2012; Lee et al., 1995).  However, the interpretation of IgM results may be complicated by 
variation in the duration of IAV IgM and the effect of prior immunity to IAV on the IgM 
response.  For example, in humans IAV serum IgM was detectable 42 to112 days after the 
onset of symptoms (Buchner et al., 1977).  In our study, serum and oral fluid IgM responses 
were obviated by vaccination.  That is, serum IgM was detected in ~98% of unvaccinated 
pigs on DPI 7, but fewer than 5% of vaccinated pigs.  Likewise, oral fluid IgM was detected 
in 100% of samples collected from pens of unvaccinated pigs on DPI 8, but only 50% of 
samples from pens of vaccinated pigs.  Correspondingly, the serum and oral fluid IgM 
responses in unvaccinated pigs was highly correlated (r = 0.81), but not in vaccinated pigs (r 
= -0.04).  Since pigs are commonly vaccinated or infected with IAV early in life in 
contemporary production systems (USDA, 2008; Yeager et al., 2008), IgM-based assays for 
serum and oral fluid may have limited utility in the field. 
 
In contrast to low IgA concentration in serum, IAV IgA predominates on mucosal surfaces 
and functions to prevent the initial attachment of IAV to the epithelial cells of the respiratory 
tract (Liew et al., 1984).  In pigs inoculated with IAV H3N2, the concentration of NP-
specific IgA antibodies in bronchoalveolar lavage and nasal wash was estimated at 280 and 
570 times, respectively, the concentration in serum at 44 DPI (Heinen et al., 2000).  In the 
current study, significant levels of serum IgA were found only at DPI 14, declining rapidly 
thereafter.  In contrast, the concentration of IgA increased rapidly in oral fluid and remained 
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elevated through DPI 42.  Consistent with these results, the correlation between serum and 
oral fluid IgA was low (r ~ 0.30).  Vaccination interfered with the serum IgA response, but 
not with the oral fluid IgA response.  That is 100 % of oral fluid samples from vaccinated 
and unvaccinated pigs were IgA positive from DPI 7 to 42.  Because of the strong IAV IgA 
response detected in oral fluid and its independence from suppression by vaccination, an oral 
fluid IgA-based assay might be useful for detecting IAV infections.  Future research in this 
line of inquiry should seek to provide additional information on oral fluid IgA kinetics over 
time and the response following exposure to homologous or heterologous subtypes. 
 
The inactivated vaccine used in this study induced a detectable serum IgG response in 41% 
of vaccinated pigs two weeks after the second dose.  Following IAV inoculation, vaccinated 
pigs showed faster and higher serum S/P IgG responses versus unvaccinated pigs.  IgG is the 
major class of serum antibody produced against IAV infection and the primary antibody 
produced in response to vaccination (Heinen et al., 2001).  In contrast to IgM, class-
switching is required to increase the affinity of IgG for IAV; which explains why IgG 
appears later in a primary infection (Graham et al., 1997; Kawabe et al., 1994).  IgG present 
in mucosal secretions is both serum-derived and produced locally (Brokstad et al., 2001; Tew 
et al., 1985; Wagner et al., 1987), but is not uniformly distributed across mucosal surfaces or 
among body fluids (Roth, 1992; Spiekermann et al., 2002).  Thus, the concentration of IgG1 
was found to be 14 times higher in bronchoalveolar lavage fluid than nasal wash (Heinen et 
al., 2000). 
 
Previous work demonstrated the presence of NP antibody in oral fluids using a blocking 
ELISA (Panyasing et al., 2012).  The current work expanded on these initial observations by 
describing the kinetics of NP-specific IgM, IgA, and IgG antibodies in oral fluid and serum 
from IAV-infected pigs.  The results of the present study showed a strong correlation (r > 
0.80) between serum and oral fluid IgG responses, an observation that justifies further 
research on the use of oral fluid antibody-based assays as a cost-effective alternative to serum 
for surveillance of IAV infections in swine populations. 
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Table 1.    Serum NP isotype-specific antibody ELISAs:  Qualitative response by treatment group and day post inoculation 
(DPI) 
 
 IgMa (% positive samples) IgAa (% positive samples) IgGa (% positive samples) 
DPI UVCTRL (n = 6) 
VCTRL 
(n = 6) 
UVH1H3 
(n = 48) 
VH1H3 
(n = 22) 
UVCTRL 
(n = 6) 
VCTRL 
(n = 6) 
UVH1H3 
(n = 48) 
VH1H3 
(n = 22) 
UVCTRL 
(n = 6) 
VCTRL 
(n = 6) 
UVH1H3 
(n = 48) 
VH1H3 
(n = 22) 
-42 0 0 0 0 0 0 0 0 0 0 0 0 
-21 0 0 0 4.5 0 16.6 0 4.5 0 0 0 4.5 
-7 0 0 4.2 18.2 0 0 4.2 13.6 0 66.7 0 40.9 
0 0 0 4.2 4.5 0 0 6.3 9.1 0 66.7 0 40.9 
7 0 0 97.9 4.5 0 0 12.5 9.1 0 66.7 6.3 100 
14 0 0 25.0 0 0 0 50.0 18.2 0 50.0 100 100 
21 0 0 4.2 4.5 0 0 39.6 18.2 0 50.0 100 100 
28 0 0 2.1 4.5 16.6 16.6 33.3 13.6 0 50.0 100 100 
35 0 0 8.3 9.1 0 16.6 20.8 13.6 0 50.0 100 100 
42 0 0 2.1 4.5 16.6 16.6 31.3 22.7 0 33.3 100 100 
 
a ROC analyses of IgM, IgA, and IgG NP ELISA (IDEXX Laboratories, Inc., Westbrook, ME) results established the optimum S/P 
cut-offs as 0.84 (IgM), 0.75 (IgA) and 0.60 IgG). 
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Table 2.    Oral fluid NP isotype-specific antibody ELISAs: Qualitative response by treatment group and day post 
inoculation (DPI) 
 
 IgMa (% positive samples) IgAa (% positive samples) IgGa (% positive samples) 
DPI UVCTRL (n = 2) 
VCTRL 
(n = 2) 
UVH1H3 
(n = 16)b 
VH1H3 
(n = 6) 
UVCTRL 
(n = 2) 
VCTRL 
(n = 2) 
UVH1H3 
(n = 16)b 
VH1H3 
(n = 6) 
UVCTRL 
(n = 2) 
VCTRL 
(n = 2) 
UVH1H3 
(n = 16)b 
VH1H3 
(n = 6) 
0 0 0 0 16.7 0 0 0 0 0 0 0 0 
1 0 0 13.3 16.7 0 0 0 33.3 0 0 0 0 
2 0 0 50.0 33.3 0 0 0 66.7 0 0 0 0 
3 0 0 56.3 66.7 0 0 21.4 66.7 0 0 0 16.7 
4 0 0 92.3 66.7 0 0 76.9 66.7 0 0 0 0 
5 0 0 92.9 66.7 0 0 78.6 66.7 0 0 0 0 
6 0 0 93.8 66.7 0 0 93.8 100 0 0 6.3 33.3 
7 0 0 100 50.0 0 0 100 100 0 0 6.3 33.3 
8 0 0 100 50.0 0 0 100 100 0 0 81.3 66.7 
9 0 0 100 16.7 0 0 100 100 0 0 100 100 
10 0 0 81.3 0 0 0 100 100 0 0 100 100 
11 0 0 75.0 0 0 0 100 100 0 0 100 100 
12 0 0 56.3 0 0 0 100 100 0 0 100 100 
13 0 0 68.8 16.7 0 0 100 100 0 0 100 100 
14 0 0 43.8 16.7 0 0 100 100 0 0 100 100 
17 0 0 31.3 0 0 0 100 100 0 0 100 100 
21 0 0 12.5 0 0 0 100 100 0 0 100 100 
28 0 0 0 0 0 0 100 100 0 0 100 100 
35 0 0 0 0 0 0 100 100 0 0 100 100 
42 0 0 0 0 0 0 100 100 0 0 100 100 
 
a ROC analyses of IgM, IgA, and IgG ELISA results established the optimum S/P cut-offs as 0.50 (IgM), 0.60 (IgA) and 0.60 
IgG).  
b Number of samples at DPIs 1 to 5 were 15, 14, 14, 13, and 14, respectively.  
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Figure 1.  Serum influenza virus A nucleoprotein IgM, IgA, and IgG mean antibody 
responses expressed as sample-to-positive (S/P) ratios over time.  Treatment 
groups included negative control pigs (UVCTRL), vaccinated control pigs 
(VCTRL), and both unvaccinated and vaccinated pigs inoculated with 
influenza A virus subtype H1N1 or H3N2 (UVH1H3 and VH1H3).  a First 
vaccination (Flusure® XP, Pfizer Animal Health, Madison, NJ), b Second 
vaccination. 
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Figure 2.  Oral fluid influenza virus A nucleoprotein IgM, IgA, and IgG mean antibody 
responses expressed as sample-to-positive (S/P) ratios over time.  Treatment 
groups included negative control pigs (UVCTRL), vaccinated control pigs 
(VCTRL), and both unvaccinated and vaccinated pigs inoculated with 
influenza A virus subtype H1N1 or H3N2 (UVH1H3 and VH1H3). 
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Figure 3.  Pearson's correlation coefficient (r) analysis of pen-level serum and oral fluid 
influenza virus A nucleoprotein IgM, IgA, and IgG sample-to-positive (S/P) 
ratios.  Unvaccinated groups included negative control pigs (UVCTRL) and 
unvaccinated inoculated pigs with influenza A virus subtype H1N1 or H3N2 
(UVH1H3).  Vaccinated groups included vaccinated control pigs (VCTRL) and 
vaccinated inoculated pigs with influenza A virus subtype H1N1 or H3N2 
(VH1H3). 
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ABSTRACT 
The feasibility of conducting influenza A virus (IAV) surveillance using pre-weaning oral 
fluid samples from litters of piglets was evaluated in four ~12,500 sow, IAV-vaccinated, 
breeding herds.  Oral fluid samples were collected from 600 litters 24 hours prior to weaning.  
Serum samples from their dams were included for comparison.  Litter oral fluid samples 
were tested for IAV by virus isolation, quantitative reverse-transcriptase polymerase chain 
reaction (qRT-PCR), RT-PCR subtyping, and sequencing.  Commercial nucleoprotein (NP) 
ELISA kits and NP isotype specific assays (IgM, IgA, and IgG) were used to characterize NP 
antibody in litter oral fluid and sow serum.  All litter oral fluid specimens (n = 600) were 
negative by virus isolation.  Twenty-five oral fluid samples were positive by qRT-PCR, based 
on screening (Laboratory 1) and confirmatory testing (Laboratory 2).  No hemagglutinin 
(HA) and neuraminidase (NA) gene sequences were obtained, but matrix (M) gene sequences 
were obtained for all qRT-PCR-positive samples submitted for sequencing (n = 18).  Genetic 
analysis revealed that all M genes sequences were identical (GenBank accession no. 
KF487544) and belonged to the triple reassortant influenza A virus M gene (TRIG M) 
previously identified in swine.  The proportion of IgM- and IgA-positive samples was 
significantly higher in sow serum and litter oral fluid samples, respectively (p < 0.01).  
Consistent with the extensive use of IAV vaccine, no difference was detected in the 
proportion of IgG- and blocking ELISA-positive sow serum and litter oral fluids.  This study 
supported the use of oral fluid sampling as a means to conduct IAV surveillance in pig 
populations and demonstrated the inapparent circulation of IAV in piglets.  Future work on 
IAV oral fluid diagnostics should focus on improved procedures for virus isolation, 
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subtyping, and sequencing of HA and NA genes.  The role of antibody in IAV surveillance 
remains to be elucidated, but longitudinal assessment of specific antibody has the potential to 
provide information regarding patterns of infection, vaccination status, and herd immunity.   
 
INTRODUCTION 
Influenza A virus (IAV) is infectious for a wide variety of vertebrate hosts and is important 
as a cause of acute respiratory disease in humans and domestic animal species (Vincent et al., 
2008).  Historically, IAV has been associated with major epidemics in humans, horses, 
poultry, and swine (Morens and Taubenberger, 2010; Shope, 1958).  IAV is an enveloped 
RNA virus composed of 8 negative-sense, single-stranded genomic segments that undergo 
rapid genetic evolution via point mutation and genetic reassortment (Brown, 2000).  
Genetically diverse, IAV subtype classification is based on two external surface proteins, 
hemagglutinin (HA) and neuraminidase (NA).  HA facilitates the attachment of the virus to 
epithelial cells in the respiratory tract via sialic acid (SA) molecules bound to galactose 
(Gal).  Among its functions, NA cleaves SA from cells to release progeny virus.  To date, 17 
HAs and 10 NAs have been identified (Tong et al., 2012; Zhu et al., 2012).  HAs from avian 
IAVs preferentially bind to SAα2,3-Gal receptors while HAs from mammalian IAVs have an 
affinity for SAα2,6-Gal receptors (Gagneux et al., 2003; Matrosovich et al., 1999).  This is 
important because differences in the distribution of SA α2,3-Gal and SA α2,6-Gal receptors 
in the respiratory tract reflect host species susceptibility to IAVs.  In quail (Coturnix 
coturnix), pheasants (ring-necked pheasants, Phasianus colchicus), chickens (Gallus gallus), 
Pekin ducks (Anas platyrhynchos domestica), both SAα2,3-Gal and SAα2,6-Gal receptors 
are present throughout the respiratory system (Yu et al., 2011).  In contrast, SA α2,6-Gal 
receptors predominate in the upper respiratory tracts of humans and pigs and SA α2,3-Gal 
receptors in the lower (Nelli et al., 2010; Shinya et al., 2006). 
 
Influenza A virus in swine is a public health issue because of concerns that reassortants 
originating in pigs could spill over to susceptible human populations.  However, IAV in 
swine is also an animal welfare issue because of its impact on pig health and productivity.  
Control of IAV in swine populations is complicated by the fact that the virus is endemic in 
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contemporary herds and may circulate in any age group, including suckling pigs (Corzo et 
al., 2012).  Commonly, more than one subtype circulates concurrently in a population (Corzo 
et al., 2013).  Ultimately, the control of IAV in swine will rely on effective interventions 
based on a sound understanding of the ecology of IAV in contemporary swine production 
systems.  This fundamental understanding can only be achieved by collecting longitudinal 
data in commercial swine herds, i.e., surveillance.  Traditionally, IAV surveillance has been 
based on collecting and testing individual pig nasal swab and/or serum samples, but the labor 
and cost of this approach makes it unacceptable for routine use.  A possible solution is 
surveillance based on pen-based oral fluid specimens.  Previous research showed that both 
IAV and anti-IAV antibody can be detected in oral fluid specimens using quantitative 
reverse-transcriptase polymerase chain reaction (qRT-PCR) and enzyme-linked 
immunosorbent assay (ELISA), respectively (Detmer et al., 2011; Panyasing et al., 2012; 
Ramirez et al., 2012; Romagosa et al. 2012).  The purpose of the current study was to 
evaluate the feasibility of IAV surveillance in breeding herds using pre-weaning oral fluid 
samples from litters of piglets. 
 
MATERIALS AND METHODS 
Experimental Design 
In four IAV-vaccinated commercial swine herds, oral fluid samples were collected from 600 
litters 24 h prior to weaning and serum samples from their dams ≤ 48 h later.  Thereafter, 
samples were completely randomized within specimen type and tested.  Oral fluid samples 
were assayed for IAV by virus isolation and qRT-PCR, followed by subtyping and 
sequencing on qRT-PCR-positive samples.  Both sow serum and litter oral fluid specimens 
were tested for IAV nucleoprotein (NP) antibody using a commercial NP blocking ELISA 
(IDEXX influenza A Ab Test, IDEXX Laboratories, Inc., Westbrook, ME) and NP isotype-
specific indirect ELISAs (IgM, IgA, and IgG).  Descriptive and comparative statistical 
analyses were used to evaluate and compare quantitative and qualitative results in serum and 
oral fluid samples, as well as significant associations with animal and herd factors.  
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Animals and animal care 
The study was conducted under the approval of the Iowa State University Institutional 
Animal Care and Use Committee (#8-11-7202-S).  The study was performed in four ~12,500 
sow breeding herds located in Oklahoma, USA.  Farm A was located ~0.8 km (0.5 miles) 
from Farm B and Farm C the same distance from Farm D.  Farms A/B were ~9.7 km (6 
miles) from farms C/D.  Gilts sources, animals housing, feeding, handling, and veterinary 
care were under the supervision of Seaboard L.L.C. Health Assurance and Welfare 
personnel.  All four herds were considered to be endemically infected with IAV on the basis 
of their diagnostic history.  Replacement gilts were routinely vaccinated with autogenous 
IAV vaccine (Newport Laboratories, Worthington, MN) at approximately 9, 12, and 24 
weeks of age and again one week post farrowing. 
 
Sample collection 
Six hundred pairs of sow serum and pre-weaning litter oral fluid samples were collected over 
a four month period by farm personnel (Table 1).  Piglets averaged 17 days of age (range: 15 
to 19 days) at the time of collection.  Oral fluid samples were collected from litters one day 
prior to weaning by suspending unbleached cotton rope (1.25 cm, 0.5 in) in the area of the 
heat mat and within access of the piglets.  When the material was saturated (15 min to 2 h), 
oral fluid was extracted by manually squeezing the rope while inside a plastic bag.  
Thereafter, the sample was transferred into a tube, held at 4˚C, and shipped to the laboratory 
on the following day.  At the laboratory, samples were aliquoted into 5 ml cryogenic vials 
and stored at -80ºC.  Within 48 h of litter oral fluid collection, sows were bled using a single-
use blood collection system (Corvac®, Tyco Healthcare Group LP, Mansfield, MA) and 
samples were shipped overnight to the laboratory.  At the laboratory, samples were 
centrifuged at 1,000 x g for 10 min, after which the serum was aliquoted into 5 ml cryogenic 
vials and stored at -80˚C.  When all samples had been collected, they were completely 
randomized and tested. 
 
Virus isolation (oral fluid) 
Confluent monolayers of MDCK cells were prepared in 48-well plates (Costar, Corning, 
Corning, NY).  Cell culture media was removed and monolayers were washed 3 times with 
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IAV wash solution composed of minimal essential medium with Earle’s salts (MEM; Sigma-
Aldrich, St. Louis, MO), 3x antibiotic-antimycotic solution [penicillin (300 IU/ml; Sigma-
Aldrich), streptomycin (300 μg/ml; Sigma-Aldrich), gentamicin (150 μg/ml; Sigma-Aldrich) 
and amphotericin B (0.75 μg/ml; Gibco, Grand Island, NY)], and TPCK-treated trypsin (2 
μg/ml; Sigma-Aldrich).  Prior to inoculation onto MDCK cells, 0.35 μl of antibiotic-
antimycotic solution was added to each 1 ml of oral fluid, after which samples were held at 
room temperature for 1 h.  Each oral fluid sample was divided among 3 wells, i.e., ~0.4 
ml/well, and then incubated at 37°C with 5% CO2 for 2 h, after which the inoculum was 
removed.  Cell monolayers were rinsed 3 times with the IAV wash solution, and then 0.4 ml 
IAV post-inoculation media composed of MEM with Earle's salts, 3x antibiotic-antimycotic 
solution, and TPCK-treated trypsin (1.5 μg/ml) was added and cell cultures were incubated 
for up to 5 days.  Cell cultures were evaluated for the appearance of cytopathic effect (CPE) 
daily.  If CPE was present, cell culture fluid was tested for HA activity and HA-positive cell 
culture fluids were tested for IAV by qRT-PCR.  Cells with no CPE were subjected to 2 
freeze-thaw cycles (-80°C and 37°C) and tested for HA activity.  Samples negative for CPE 
and/or HA were subjected to a second cell culture passage by pooling the fluid from all 3 
wells and then re-inoculating fresh confluent MDCK cells in 3 wells. Samples were 
considered negative if CPE and HA were negative after the second passage on cell culture.  
Contaminated cell culture fluids were considered “not determined”. 
 
Influenza A virus oral fluid qRT-PCR (Laboratory 1) 
RNA extraction was performed on oral fluid specimens using the MagMAX™ Viral RNA 
Isolation Kit (Life Technologies, Carlsbad, CA) and a Kingfisher 96 instrument (Thermo 
Scientific, Waltham, MA) using the high volume modified lysis (HVML) procedure.  The 
lysis/binding solution for the HVML protocol was prepared using 45 ml lysis/binding 
solution with 200 μl carrier RNA without the addition of isopropanol.  For the lysis step, 300 
μl of sample was added to 450 μl of modified lysis/binding solution.  Xeno™ internal control 
RNA was added to the lysis-binding solution at 4,000 copies per reaction prior to extraction 
to monitor PCR amplification and detect inhibition.  The sample, lysis/binding solution, and 
internal control RNA were vortexed for 3 min and centrifuged at 2,500 x g for 6 min.  A 
volume of 600 μl of lysate was added to 350 μl isopropanol with 20 μl magnetic bead mix 
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prior to extraction and elution into 90 μl buffer.  The HVML used 300 and 450 μl of wash 
solutions I and II, respectively.  The HVML extraction was conducted using the Kingfisher 
program AM1836_DW_HV_v3. 
 
Influenza A virus qRT-PCR was performed on nucleic acid extracts according to the 
manufacturer's instructions using PCR reagents with multiple primers and probes targeting 
different genomic regions (MagMAX™ Gold SIV Detection Kit, Life Technologies).  One 
positive extraction control, one positive amplification control, one negative extraction 
control, and a negative amplification control were included with each extraction and/or PCR 
run.  Each oral fluid reaction included 12.5 μl of 2X multiplex RT-PCR buffer, 1.0 μl of 25X 
SIV primer probe mix, 2.5 μl of 10X multiplex RT-PCR enzyme mix, and 1.0 μl of nuclease-
free water.  A final volume of 25 μl, consisting of 17 μl master mix and 8 μl of RNA extract, 
was placed in each well of a 96-well fast PCR plate (Life Technologies).  qRT-PCR was 
performed using an AB 7500 fast thermocycler: 1 cycle at 48°C for 10 min, 1 cycle at 95°C 
for 10 min, and 40 cycles of 95°C for 15 sec, 60°C for 45 sec.  Amplification curves were 
analyzed with commercial thermal cycler system software.  The cycle threshold was set at 
0.2 and the “auto baseline” was used to determine fluorescence baselines.  Samples with Ct 
values < 38 were considered positive.  Internal control Xeno™ RNA Ct values were set at 
10% of maximum. 
 
Influenza A virus oral fluid qRT-PCR (Laboratory 2) 
Oral fluid samples identified as IAV qRT-PCR positive (n = 22) at Laboratory 1 were 
submitted with qRT-PCR negative oral fluid samples (n = 44) to Laboratory 2 for 
confirmatory testing (Tetracore®, Inc., Rockville, MD). 
 
Prior to RNA extraction, 180 μl of sample was centrifuged (14,000 x g for 30 sec) and then 
140 μl of the supernatant was manually lysed in a biosafety cabinet.  Nucleic acids were 
extracted and purified from the lysate according to the manufacturer’s recommendations 
using the QIAGEN® QIAamp® Viral Mini QIAcube® kit (Catalog #52926, Qiagen, Inc., 
Valencia, CA) on the QIAGEN® QIAcube® processor (Qiagen, Inc.).  The inhibition control 
(IC) was used as an extraction and PCR inhibition control for each sample. 
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The qRT-PCR procedure was performed using commercial reagents (Universal Influenza A 
Matrix MPX 2.0, Tetracore®, Inc.) and the dry master mix was prepared according to the 
manufacturer’s recommendations.  The reactions were run (Applied Biosystems® 7500 Fast 
Real-Time PCR System, Applied Biosystems®, Foster City, CA): 50°C for 30 min (reverse 
transcription), then 95°C for 2 min (RT inactivation/initial denaturation), followed by 40 
cycles of 95°C for 15 sec, 52°C for 15 sec, and 60°C for 33 sec (amplification).  The 
thermocycler was run in “standard” mode and fluorescence data was collected during the 
60°C step in the FAM™ and CY5 channels.  A sample was considered positive for the IAV 
matrix target if it yielded a Ct of < 37. 
 
Influenza A virus subtyping (Laboratory 1) 
Hemagglutinin (HA) and neuraminidase (NA) subtyping was performed on qRT-PCR-
positive IAV nucleic acid extracts using Swine Influenza Virus Subtyping RNA Reagents 
(Life Technologies, Carlsbad, CA).  Separate RT-PCR reactions were used to detect the 
presence of H1 or H3 HA or N1 or N2 NA, respectively.  Each oral fluid reaction included 
12.5 μl of 2X multiplex RT-PCR buffer, 1.0 μl of 25X H1H3 or N1N2 Primer Probe Mix, 2.5 
μl of 10X multiplex RT-PCR enzyme mix, and 1.0 μl of nuclease-free water.  Each subtyping 
plate included the same positive and negative controls used in the SIV general RT-PCR 
reaction.  The IAV general RT-PCR cycling conditions were used for RT-PCR subtyping and 
amplification curves were analyzed with commercial thermal cycler system software using 
the same cycle threshold and “auto baseline” determinants as the IAV general RT-PCR.  
Samples with Ct values < 38 were considered positive. 
 
Influenza A virus sequencing (HA, NA and M gene) 
Whole genome HA, NA, and matrix (M) genes were sequenced using conventional methods.  
Viral RNA was extracted using the Ambion MagMAXTM-96 AI/ND (Life Technologies) and 
a Kingfisher 96 instrument (Thermo Scientific).  Specifically, 50 μl of sample, 100 μl of viral 
lysis/binding solution with carrier RNA, and 20 μl of bead solution were used with 100 μl of 
the wash solution supplied with the kit.  The final extracted sample elution volume was 50 μl.  
The extractions were performed using the Kingfisher program AM_1835_DW_NVSL.  RT-
PCR was conducted for each gene segment using the primers described in Table 2 and the 
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FideliTaqTM RT-PCR Master Mix (2X) kit (Affymetrix, Cleveland, OH).  The sequencing 
RT-PCR setup reaction used 200 nM of each primer with 25 μl 2X RT-PCR master mix and 
9 μl or 13 μl nuclease-free water for the HA or NA/M genes, respectively.  The final volume 
of 50 μl consisted of 38 μl or 42 μl master mix and 12 μl or 8 μl of RNA extract for the HA 
or NA/M genes, respectively.  One positive extraction control (H1 or H3), one negative 
extraction control, and one negative amplification control were included with the reaction.  
RT-PCR was performed using an ABI 2720 thermal cycler: 1 cycle at 48°C for 30 min, 1 
cycle at 95°C for 3 min, 50 cycles of 94°C for 30 sec, 48°C for 30 sec, and 68°C for 120 sec.  
The final elongation step was 68°C for 5 min.  Detection of the RT-PCR product, HA at 1800 
base pairs (bp), the NA at 1500 bp and M at 1100 bp, was performed on a QIAxcel® 
(Qiagen, Inc.) capillary electrophoresis system using a DNA screening cartridge and the 
AM420 method and purified with ExoSAP-IT PCR cleanup reagent (Affymetrix) following 
the manufacturer’s recommendations.  Samples were submitted to the Iowa State University 
DNA facility (Ames, IA) for sequencing.  Lasergene® software (DNAStar, Madison, WI) 
was used to compile sequences. 
 
Serum NP blocking ELISA 
Sow serum samples were tested for NP antibodies using a commercial blocking ELISA 
performed as recommended by the manufacturer (IDEXX Influenza A Ab Test, IDEXX 
Laboratories, Inc.).  Reactions were measured as optical density (OD) at a wavelength of 650 
nm using an ELISA plate reader (BioTek® Instruments Inc., Winooski, VT), operated with 
commercial software (GEN5™, BioTek® Instruments Inc.).  Sample-to-negative (S/N) ratios 
were calculated as described by the manufacturer, with S/N ratios ≤ 0.60 considered antibody 
positive (Goodell et al., 2013a). 
 
Serum NP isotype-specific indirect ELISAs 
Sow serum samples were assayed for anti-NP IgM, IgA, and IgG using indirect ELISAs.  
Plates and reagents (sample diluent, substrate, stop solution, and wash solution) were from a 
commercial IAV blocking ELISA (IDEXX Influenza A Ab Test, IDEXX Laboratories, Inc.) 
and conjugate diluent from a commercial indirect ELISA (IDEXX PRRS X3 Ab Test, 
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IDEXX Laboratories, Inc.).  Detection of isotype-specific NP antibody utilized horseradish 
peroxidase (HRP) conjugated goat anti-pig IgM (A100-100P), IgA (A100-102P), and IgG 
(A100-104P) antibody (Bethyl Laboratories Inc., Montgomery, TX) diluted in conjugate 
diluent.  Duplicate in-house negative and positive serum controls (IgM, IgA, and IgG) were 
used to validate plate performance and to calculate sample-to-positive (S/P) ratios. 
 
To perform the assay, serum samples were diluted 1:50 (IgM), 1:10 (IgA), or 1:50 (IgG), 
then plates were loaded (100 µl) with samples, negative and positive controls (IgM, IgA, or 
IgG).  After 2 h incubation at 37˚C, plates were washed 3 times, then 100 µl of diluted HRP-
conjugated goat anti-pig IgM (1:8,000) or IgA (1:2000) or IgG (1:10,000) was added to each 
well and the plates incubated at 37 ˚C for 1 h.  Plates were then washed 3 times, after which 
100 µl of 3, 3’, 5, 5’- tetramethyl benzidine (TMB) substrate was added.  After 15 min 
incubation at room temperature, 100 µl of stop solution was added and plates read at a 
wavelength of 650 nm.  S/P ratios were calculated for each sample as: 
 
S/P ratio = 
(sample OD – negative control mean OD) 
  ____________________________________________________________________________________________________________________________________ 
(positive control mean OD – negative control mean OD) 
 
Oral fluid NP blocking ELISA 
Oral fluid samples were assayed for IAV antibody using a commercial blocking ELISA 
(IDEXX Influenza A Ab Test, DEXX Laboratories, Inc.) performed as described elsewhere 
(Panyasing et al., 2012).  Briefly, each plate was loaded with undiluted oral fluid samples 
(200 µl), kit negative and positive controls, and in-house oral fluid controls (low, medium, 
high) and incubated for 16 h at 22 °C.  Thereafter, the assay was performed and S/N ratios 
calculated as described by the manufacturer. 
 
Oral fluid NP isotype-specific indirect ELISAs 
The oral fluid NP isotype-specific indirect ELISAs are described elsewhere (Panyasing et al., 
2013).  Briefly, oral fluid samples were assayed on ELISA plates manually coated with one 
µg/well of commercially-produced NP antigen (Cat no. IMR-274, Imgenex© Corporation, 
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San Diego, CA).  The reagents used in the ELISAs were identical to the serum NP-isotype 
specific assays, with the exception of IgM, IgA, and IgG conjugate concentrations.  To 
perform the assays, plates were loaded with undiluted oral fluid specimens (200 µl) and pre-
diluted negative (100 µl) and positive (100 µl) in-house plate controls (in duplicate) and 
incubated at 4˚C for 16 h.  After incubation, plates were washed 3 times.  To detect IgM, 
IgA, and IgG, 100 µl of HRP-conjugated goat anti-pig IgM (1:2,000), IgA (1:2000) or IgG 
(1:1,500) was added and the plates incubated at 37˚C for 1 h.  Plates were then washed 3 
times, TMB substrate (100 µl) added, and the plates incubated at room temperature for 15 
min.  Stop solution (100 µl) was then added and the plates read immediately thereafter.  
Reactions were measured at a wavelength of 650 nm and S/P ratios calculated. 
 
Statistical analysis 
Oral fluid qRT-PCR qualitative responses were analyzed for significant differences among 
herds and sampling time points (Fisher’s Exact test) and significant associations with sow 
parity and litter size (Wilcoxon-Mann-Whitney test) using commercial software (SAS® 9.2, 
SAS® Institute Inc., Cary, NC).  The M gene nucleotide sequences were compared with a 
variety of classical and recent North American swine-derived IAV full-length M gene 
sequences available in the GenBank database.  A phylogenetic tree was generated by the 
distance-based, neighbor-joining method using MEGA5.2 software (Tamura et al., 2011).  
Serum and oral fluid S/P and S/N antibody responses were analyzed for significant 
associations with sow parity, litter size, herd, sampling time point, qRT-PCR response, and 
their interactions by analysis of variance (ANOVA).  The relationship between IgM, IgA, 
and IgG S/P ratios in serum versus oral fluid samples was evaluated by correlation analysis 
(Pearson’s correlation coefficient). 
 
RESULTS 
Detection of Influenza A virus in oral fluid 
All oral fluid specimens (n = 600) were negative by virus isolation.  IAV qRT-PCR testing in 
Laboratory 1 identified 22 (3.7 %) positive oral fluid samples (Table 3).  Ten of the 22 
positive samples were successfully subtyped, with most shown to be mixed infections (H1, 
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H3, N1, and N2).  To confirm the qRT-PCR results, the 22 positive samples plus 44 
randomly-selected qRT-PCR-negative samples were submitted to Laboratory 2.  Testing at 
Laboratory 2 identified 18 qRT-PCR positive samples, including 3 that had previously tested 
negative at Laboratory 1.  Among the cumulative total of 25 qRT-PCR positive samples 
reported by Laboratory 1 and/or Laboratory 2, 18 were available for sequencing, i.e., 7 
samples had been depleted.  None of the attempts to sequence HA and NA genes was 
successful, but M gene sequences were obtained for all 18 samples.  Genetic analysis 
revealed that the 18 M gene nucleotide sequences were100% identical to each other 
(GenBank Accession number KF487544) and to the M gene of a previous GenBank 
submission (JX444793/A/swine/Ohio/A01203624/2012(H3N2) (Figure 1). 
 
As shown in Table 1, the cumulative proportion of IAV qRT-PCR-positive oral fluid samples 
by farm (high to low) was: Farm B (15/145, 10.3%), Farm D (7/150, 4.7%), Farm A (2/153, 
1.3%), Farm C (1/152, 0.7%).  Pairwise comparisons showed that the proportion of qRT-
PCR positives in Farm B differed significantly from Farms A and C (Fisher's Exact Test, p < 
0.001), but not from Farm D (p = 0.07).  In Farm B, 14 of the 15 total qRT-PCR positive oral 
fluid samples were recovered at one sampling point, i.e., calendar week 28.  Similarly in 
Farm D, 5 of the 7 total qRT-PCR positive oral fluid samples were detected in the samples 
collected at week 30.  No association was detected between IAV qRT-PCR oral fluid status 
and sow parity or the number of pigs weaned (Wilcoxon Mann-Whitney test, p > 0.05). 
 
IAV NP antibody in sow serum and litter oral fluid samples 
Qualitative results of IAV NP antibody testing of sow serum and litter oral fluid are shown in 
Table 4.  The proportion of IgM, IgA, IgG, or blocking ELISA-positive sow serum or litter 
oral fluid samples did not differ among herds or within farms by calendar week.  A 
comparison of sow serum and litter oral fluids qualitative results found no difference in the 
proportion of IgG or blocking ELISA positives, but the proportion of IgM and IgA positives 
was higher in sow serum and litter oral fluid, respectively (Fisher’s Exact Test, p < 0.01).  No 
association was detected between IAV qRT-PCR oral fluid results and IgM, IgA, IgG, or 
blocking ELISA qualitative results in sow serum or litter oral fluid samples (Fisher’s Exact 
Test, p > 0.20). 
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Sow serum and litter oral fluid IgM, IgA, IgG, and blocking ELISA quantitative responses 
(S/P and S/N ratios) are shown in Figure 2.  No significant association was detected between 
sow serum or liter oral fluid antibody responses and farm, sow parity, number of pig weaned, 
calendar week, or IAV qRT-PCR oral fluid results.  Evaluation of the association between 
litter oral fluid and sow serum antibody responses showed a significant association between 
IgG S/P ratios (p = 0.01, r = 0.10), but not between IgM, IgA, or blocking ELISA responses. 
 
DISCUSSION 
Influenza A virus surveillance in susceptible species is necessary to monitor viral evolution 
and support the development of improved diagnostic tests and more efficacious vaccines 
(Vincent et al., 2013).  More narrowly, research on the ecology of IAV in swine populations 
is motivated by concerns that reassortants originating in pigs could prove to be virulent in 
humans and by the need to ameliorate the negative effects of IAV on pig welfare and health.  
Historically, the collection of longitudinal infectious disease data in commercial herds has 
been constrained by the expense and inconvenience of collecting and testing specimens from 
individual animals.  As an alternative, we evaluated the feasibility of conducting IAV 
surveillance using oral fluid samples collected from litters of piglets prior to weaning.  This 
age group was selected under the premise that surveillance data from this group would allow 
producers to identify and respond to health issues in the breeding herd and anticipate post-
weaning disease issues in growing pig populations.  Serum samples collected from each 
litters' dam provided for comparisons with litter oral fluid testing results.  Oral fluid and 
serum samples were collected by farm personnel and then sent to the laboratory for testing.  
This approach avoided the biosecurity risks invariably associated with sending outside 
personnel into a herd to collect samples. 
 
The results of the study showed that IAV could be detected by qRT-PCR, subtyped, and 
sequenced using oral fluid specimens collected from neonatal pigs.  All attempts at virus 
isolation from oral fluids were negative, but virus subtyping revealed that infections were 
commonly a mix of subtypes H1, H3, N1, and N2.  Cumulatively, the results showed a 
pattern of intermittent subclinical IAV infections in litters from IAV-vaccinated dams, with 
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infrequent episodes involving larger numbers of litters.  These results are in accord with the 
view that IAV circulates throughout the year in contemporary swine populations (Van Reeth 
et al., 2012).  The absence of clinical losses was consistent with reports that maternal 
immunity can moderate fever, reduce clinical signs, and prolong virus shedding, but not 
prevent infection (Allerson et al., 2013; Kittikoon et al., 2006; Loeffen et al., 2003).  These 
results were compatible with previous reports.  Evaluating the detection of IAV in oral fluids 
by qRT-PCR as a function of within-pen prevalence, Romagosa et al. (2012) estimated the 
probability of detecting one acutely-infected pig in a pen of 11 at 69% and 2 infected pigs at 
99%.  Detmer et al. (2011) reported successful subtyping, HA gene sequencing, and IAV 
isolation from oral fluid field samples, albeit virus isolation is generally more successful 
using nasal swabs (Goodell et al., 2013b). 
 
Although the study was not designed to compare assay reproducibility, serial testing of a 
subset of samples showed that false negative results occurred in both laboratories performing 
qRT-PCR testing.  That is, IAV M gene sequencing was successful on all qRT-PCR-positive 
samples submitted for sequencing (n = 18, Table 3), even if the sample tested negative in one 
of the two laboratories.  HA and NA gene sequences were not obtained, but analysis of M 
gene sequences (n = 18) showed 100% nucleotide identity to each other and a previous 
GenBank submission in the TRIG M cluster (JX444793/A/swine/Ohio/A01203624/2012(H3N2)).  
The length and genetic diversity of the HA (~1,700 nucleotides) and NA (~1,400 
nucleotides) genes may account for the difficulty in sequencing these genes, as opposed to 
the highly conserved and shorter M gene (~1,000 nucleotides) (Lamb and Krung, 2001).  
This problem may be resolved in the future as assays are improved. 
 
Previous research described the ontogeny of IAV NP antibody responses over time in oral 
fluid (Panyasing et al., 2012), serum, bronchoalveolar and nasal lavage fluid (Heinen et al., 
2000) from pigs under experimental conditions.  In the present study, nearly all serum and 
oral fluid samples were positive for NP IgG antibody due to the extensive use of IAV vaccine 
and the concomitant circulation of wild-type IAV in these populations.  Although IgM and/or 
IgA positive maternal serum and piglet oral fluid samples were identified, no association was 
detected between IAV qRT-PCR results and NP antibody profiles (IgM, IgA, IgG, and 
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blocking ELISAs).  In part, the ability to detect patterns of antibody response to infection 
was compromised by the experimental design, i.e., samples were collected at a single point in 
time from each litter or sow. 
 
Overall, the present study supports the use of oral fluid sampling as a means to conduct IAV 
surveillance in pig populations.  In particular, oral fluid offers the potential to conduct 
surveillance with fewer samples than required for individual pig testing.  Future work on 
IAV oral fluid diagnostics should focus on improved procedures for virus isolation, 
subtyping, and sequencing of HA and NA genes.  The role of antibody in IAV surveillance 
remains to be determined, but longitudinal assessment of specific antibody could provide 
information regarding patterns of infection, vaccination status, and herd immunity. 
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Table 1.    Count of matched sow serum and litter oral fluid (OF) samples and influenza A virus (IAV) qRT-PCR-positive OF 
samples 
 
 ------------------------------ Calendar week and month ----------------------------  
 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34  
Samples by farma May  June July August n 
Farm A - samples (serum and OF) 11 • • • 33 33 • 40 36 • • • • • • 153 
      IAV qRT-PCR-positive OF samples 0 • • • 0 0 • 2 0 • • • • • • 2 
Farm B - samples (serum and OF) 18 5 17 • • 15 • • 42 24 24 • • • • 145 
      IAV qRT-PCR-positive OF samples 1 0 0 • • 0 • • 14 0 0 • • • • 15 
Farm C - samples (serum and OF) • • • • • • • • • • • 51 52 32 17 152 
      IAV qRT-PCR-positive OF samples • • • • • • • • • • • 1 0 0 0 1 
Farm D - samples (serum and OF) • • • • • • • • • • 30 30 35 42 13 150 
      IAV qRT-PCR-positive OF samples • • • • • • • • • • 5 0 0 1 1 7 
Total samples (serum and OF) 29 5 17 0 33 48 0 40 78 24 54 81 87 74 30 600 
      IAV qRT-PCR-positive OF samples 1 0 0 0 0 0 0 2 14 0 5 1 0 1 1 25 
 
a All gilts were vaccinated with autogenous influenza A virus vaccine at approximately 9, 12, and 24 weeks of age and then 1 week 
post farrowing.  
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Table 2.    Primer sets used for RT-PCR amplification of hemagglutinin (HA), 
neuraminidase (NA) and matrix (M) genes of influenza A viruses 
 
Target  Primer Primer Sequence 5'-3' 
H1 H1-F AAGCAAAAGCAGGGGAAAATAA 
  HR AGTAGAAACAAGGGTGTTTTT 
H3 H3-F AGCAAAAGCAGGGGATAATTCT 
  HR AGTAGAAACAAGGGTGTTTTT 
NA NA-1F TAT TGG TCT CAG GGA GCA AAA GCA GGA GT 
NA NA-1413R ATA TGG TCT CGT ATT AGT AGA AAC AAG GAG TTT TTT 
M M-1F TAT TCG TCT CAG GGA GCA AAA GCA GGT AG 
M M-1027R ATA TCG TCT CGT ATT AGT AGA AAC AAG GTA GTT TTT 
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Table 3.    Summary of test results on influenza A virus qRT-PCR-positive litter oral fluid samples and matched sow serum  
 
   Sow serum Pre-weaning litter oral fluid samples 
Farm Sow parity 
Pigs 
weaned 
IgM 
(S/P) 
IgA 
(S/P) 
IgG 
(S/P) 
Lab1a Ct 
qRT-PCR 
Lab2b Ct 
qRT-PCR Virus subtyping 
M gene 
sequencing 
IgM 
(S/P) 
IgA 
(S/P) 
IgG 
(S/P) 
A 3 11 0.63 0.18 2.92 >38.0 36.62 ND Y 0.40 0.01 2.75 
A 2 12 0.17 0.58 2.51 37.70 >37.0 Untypable Y 0.02 0.12 2.87 
B 4 10 0.52 0.75 2.62 30.70 32.32 H1, H3, N1, N2 Y 0.10 0.01 2.77 
B 3 11 0.58 0.77 2.67 37.80 35.51 Untypable QNSc 0.04 0.05 2.52 
B 6 11 0.56 0.37 2.42 28.70 29.67 H1, H3, N1, N2 Y 0.08 0.02 2.70 
B 6 11 0.51 0.32 2.44 33.0 30.99 H1 Y 0.22 0.03 2.63 
B 6 12 0.02 0.54 2.19 33.30 34.12 H1 Y 0.09 0.07 2.41 
B 3 11 0.11 0.56 2.41 32.10 31.82 H1, H3 QNS 0.17 0.15 1.37 
B 3 11 0.73 0.65 2.39 31.60 32.31 H1, N2 QNS 0.12 0.03 2.58 
B 1 11 0.02 0.44 2.26 36.10 >37.0 Untypable Y 0.06 0.42 3.00 
B 4 11 0.82 0.44 2.48 34.70 33.08 Untypable Y 0.14 0.12 2.52 
B 4 12 0.12 0.01 2.52 24.20 26.66 H1, H3, N1, N2 Y 0.02 0.08 2.63 
B 6 11 0.44 0.21 2.42 35.90 36.21 Untypable Y 0.16 0.11 2.57 
B 2 11 0.59 0.17 1.65 28.10 31.25 H1, H3, N1, N2 Y 0.12 0.00 2.15 
B 6 10 0.02 0.57 2.56 32.00 32.14 Untypable Y 0.16 0.07 2.59 
B 6 12 0.91 0.36 2.43 34.60 33.08 H1 Y 0.03 0.02 2.68 
B 2 11 0.27 0.73 1.88 28.70 >37.0 H1, H3, N1, N2 Y 0.08 0.12 2.37 
C 2 9 0.05 0.21 2.14 >38.0 29.64 ND Y 0.30 1.35 1.93 
D 3 10 0.33 0.58 2.78 >38.0 35.48 ND Y 0.05 0.04 2.26 
D 3 10 0.95 0.49 2.65 36.00 36.88 Untypable QNS 0.16 0.06 2.22 
D 2 11 0.00 0.26 2.47 36.87 >37.0 Untypable QNS 0.16 0.03 1.66 
D 5 11 0.55 0.68 2.63 33.60 >37.0 Untypable QNS 0.19 0.09 1.09 
D 1 10 1.00 0.53 2.21 37.40 >37.0 Untypable Y 0.00 0.44 1.60 
D 4 10 0.89 0.49 2.56 36.90 36.58 Untypable Y 0.08 0.03 2.61 
D 1 12 0.22 0.54 2.13 37.70 >37.0 Untypable QNS 0.09 0.06 2.76 
 
a Cts < 38 were positive in Laboratory 1.  b Cts < 37 were positive in Laboratory 2.  c Quantity not sufficient (QNS) for testing.
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Table 4.    Influenza A virus nucleoprotein (NP) antibody ELISA (IgM, IgA, IgG, blocking) qualitative testing results 
 
  Count of ELISA-positive sow serum samples Count of ELISA-positive litter oral fluid samples 
Farma n IgMb IgAb IgGb  Blockingc IgMd IgAd IgGd  Blockinge 
A 153 16 5 153 148 0 13 152 145 
B 145 16 3 144 135 4 10 145 134 
C 152 22 4 152 142 1 12 152 142 
D 150 12 4 150 143 1 4 150 143 
Total 600 66 16 599 568 6 39 599 564 
 
a All gilts were vaccinated with autogenous influenza A virus vaccine at approximately 9, 12, and 24 weeks of age and then 1 
week post farrowing. 
b Indirect ELISA S/P ratios ≥ 0.84 (IgM), ≥ 0.75 (IgA) or ≥ 0.60 (IgG) were considered antibody positive (Panyasing et al., 2013). 
c Blocking ELISA S/N ratios ≤ 0.60 were considered antibody positive (Goodell et al., 2013a). 
d Indirect ELISA S/P ratios ≥ 0.50 (IgM), ≥ 0.60 (IgA) or ≥ 0.60 (IgG) were considered antibody positive (Panyasing et al., 2013). 
e Blocking ELISA S/N ratios ≤ 0.60 were considered antibody positive (Panyasing et al., 2012). 
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Figure 1.  Phylogenetic tree based on an analysis of the matrix (M) genes of influenza A viruses detected in North 
American swine available through GenBank. The viruses detected in this study are indicated with a solid 
diamond ♦.  The tree was constructed using the distance-based, neighbor-joining method (MEGA5.2; Tamura 
et al., 2011).  The reliability of the tree was assessed by a bootstrap analysis with 1000 replications.  Scale bars 
indicate nucleotide substitutions per site. 
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Figure 2.  Influenza A virus nucleoprotein (NP) antibody ELISA (IgM, IgA, IgG, 
blocking) quantitative testing results. 
 
97 
 
 
 
CHAPTER 6.  GENERAL CONCLUSIONS 
Influenza A virus (IAV) research in swine began with Shope's (1931) work with "infectious 
material" in 1930.  This line of research continues in full force today because IAV remains 
endemic in pig populations, causing significant economic losses to pork producers and 
fueling on-going public health concerns.  Despite 80-plus years of research, we lack the 
knowledge to achieve effective control of IAV in swine.  We suggest that one of the missing 
elements is an understanding of IAV at the population level and that this lack can only be 
provided by surveillance.   
 
Viable surveillance systems should be designed based on the criteria described by Klaucke et 
al. (1998):  simple (easy to operate), flexible (adaptable to changing conditions and needs), 
acceptable (individuals and organizations choose to participate), timely (data enter the system 
quickly), and accurate.  Animal disease surveillance programs have historically met few of 
these criteria.  To the contrary, surveillance has historically been labor-intensive, costly, and 
slow -- attributes that have generally precluded it from achieving the utility necessary for it to 
fulfill its function (Pappaioanou and Gramer, 2010).   
 
The use of oral fluid sampling can expedite IAV surveillance in swine populations because it 
is welfare-friendly, worker-friendly, cost-effective, and diagnostically efficient.  For 
example, IAV qRT-PCR testing of pen-based oral fluids showed increased analytical 
sensitivity when compared to individual animal samples (Romagosa et al. 2012).  Evaluating 
the detection of IAV in oral fluids by qRT-PCR as a function of within-pen prevalence, 
Romagosa et al. (2012) estimated the probability of detecting one acutely-infected pig in a 
pen of 11 at 69% and 2 infected pigs at 99%.  The work reported in this dissertation showed 
that this approach is also amenable to the genetic characterization of IAV isolates using 
molecular technology, e.g., RT-PCR subtyping and sequencing (Chapter 5).   
 
Antibody-based assays have historically played a large role in surveillance.  In the case of 
IAV, antibody detected in oral fluid had a marked advantage over virus detection by isolation 
or RT-PCR in terms of the longevity of detection.  That is, IAV is rarely detected in pigs 
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beyond the first week of infection (Van Reeth et al., 2012) whereas oral fluid antibody was 
for ≥ 42 days post inoculation and correlated with serum antibody (r ~0.80) (Chapter 3 and 
4).  Notably, the IAV oral fluid nucleoprotein (NP) antibody assay described in this 
dissertation demonstrated the capacity to detect multiple IAV subtypes.  Specifically, no 
difference was found in the detection of oral fluid NP antibody between H1N1 and H3N2 
inoculated pigs (Chapter 3 and 4).  This is an example of a screening assay based on the 
detection of antibody targeting conserved elements of the virus, in this case the viral 
nucleoprotein (NP).  Indeed, NP is so highly conserved among IAV subtypes that antibody 
assays targeting this protein can detect IAV infections across subtypes, as well as host 
species.   
 
Future research should continue to explore diagnostic applications of oral fluid for the 
purpose of improving IAV surveillance.  Areas of investigation should include the evaluation 
of other IAV conserved elements, e.g.., nonstructural proteins (NS) and matrix protein (M) 
for “universal” IAV antibody detection and for their use in differential vaccines and 
diagnostic assays based on the presence (positive DIVA) or absence (negative DIVA) of 
specific protein(s) in the vaccine.  Indeed, several different DIVA strategies have been 
proposed for surveillance of avian influenza (Suarez, 2005) and some of them could 
potentially be used in swine.  These would include subunit vaccines targeted to the 
hemagglutinin (HA) or neuraminidase (NA) proteins or vaccines missing specific internal 
viral proteins, e.g., matrix (M), nonstructural protein 1 (NS1), or NP.  Concurrent 
development of the vaccine and oral fluid diagnostic assays could provide a powerful tool for 
the control IAV in swine population by facilitating a method to effectively identify infected 
populations.  Overall, it is important that research on the diagnostic applications of oral fluid 
continues because of its potential to provide the ecologic information necessary to achieve an 
effective control strategy for IAV in swine. 
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